Processing 00000000.tx.1: Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan S.-Y. 

Phrase: "Clinical significance of cytogenetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2826293:Clinical Significance [Finding]
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "interphase fluorescence in situ hybridization analysis in newly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "multiple myeloma in Taiwan"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   770   C0439064:Multiple [Quantitative Concept]
   770   C3538749:Myeloma [Intellectual Product]

Phrase: "S.-"

Phrase: "Y."
Processing 00000000.tx.2: Huang1, M. 

Phrase: "Huang1,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Yao1, J.-L. 

Phrase: "Yao1,"

Phrase: "J.-L."
Processing 00000000.tx.4: Tang1, W. 

Phrase: "Tang1,"

Phrase: "W."
Processing 00000000.tx.5: Tsay1, F.-Y. 

Phrase: "Tsay1,"

Phrase: "F.-Y."
Processing 00000000.tx.6: Lee2, M.-C. 

Phrase: "Lee2,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.7: Liu2, C.-H. 

Phrase: "Liu2,"

Phrase: "C.-H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.8: Wang3, Y.-C. 

Phrase: "Wang3,"

Phrase: "Y.-C."
Processing 00000000.tx.9: Chen3, M.-C. 

Phrase: "Chen3,"

Phrase: "M.-C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.10: Shen3 and H.-F. 

Phrase: "Shen3"

Phrase: "and"

Phrase: "H.-F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.11: Tien1,* Departments of 1 Internal Medicine, 2 Pathology and 3 Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan * Correspondence to: Dr H.-F. 

Phrase: "Tien1,"

Phrase: "* Departments of 1 Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704729:Department [Organization]

Phrase: "2 Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "3 Laboratory Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013227:Medicine, NOS [Pharmacologic Substance]
   827   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "National Taiwan University Hospital,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0039260:Taiwan [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1510665:Hospital [Qualitative Concept]
   812   C3245503:national [Intellectual Product]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Taipei,"

Phrase: "Taiwan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "* Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Dr H.-F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.12: Tien, Department of Internal Medicine, National Taiwan University Hospital, No. 

Phrase: "Tien,"

Phrase: "Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "National Taiwan University Hospital,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0039260:Taiwan [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1510665:Hospital [Qualitative Concept]
   812   C3245503:national [Intellectual Product]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "No."
Processing 00000000.tx.13: 7, Chung-Shan South Road, Taipei, Taiwan, ROC. 

Phrase: "7,"

Phrase: "Chung-Shan South Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Taipei,"

Phrase: "Taiwan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "ROC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683187:ROC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527113:ROC [Quantitative Concept]
Processing 00000000.tx.14: Tel: +886-2-23970800, ext. 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+886-2-23970800,"

Phrase: "ext."
Processing 00000000.tx.15: 3955; 

Phrase: "3955"

Phrase: ";"
Processing 00000000.tx.16: Fax: +886-2-23959583; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+886-2-23959583"

Phrase: ";"
Processing 00000000.tx.17: Email: hftd{at}ha.mc.ntu.edu.tw  Abstract Top Abstract Introduction Patients and methods Results Discussion References  Background: The incidence of multiple myeloma (MM) is lower in Asia than in Western countries. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "hftd{at}ha.mc.ntu.edu.tw  Abstract Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: ":"

Phrase: "The incidence of multiple myeloma (MM)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "is"

Phrase: "lower in Asia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in Western countries."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454664:Countries [Geographic Area]
Processing 00000000.tx.18: However, it is not known whether cytogenetic abnormalities (CA) characteristic of MM in Asia differ from those documented in the West. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "whether"

Phrase: "cytogenetic abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0008625:Cytogenetic Abnormalities [Cell or Molecular Dysfunction]
  1000   C0008626:Cytogenetic Abnormalities [Disease or Syndrome]
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "(CA) characteristic of MM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "in Asia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003980:Asia [Geographic Area]
   928 E C0078988:Asian [Population Group]

Phrase: "differ from those"

Phrase: "documented in the West."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   770   C1705493:West [Spatial Concept]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.19: Patients and methods: We analyzed CA by conventional cytogenetics (CG) and/or fluorescence in situ hybridization (FISH), assessed their clinical significance in 150 Chinese MM patients and compared our data with that derived from Western countries. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "CA by conventional cytogenetics (CG)"

Phrase: "and/or"

Phrase: "fluorescence in situ hybridization (FISH),"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "their clinical significance in 150 Chinese MM patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C2826293:Clinical Significance [Finding]
   742   C0237881:Significance [Quantitative Concept]
   742   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "our data with that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "derived from Western countries."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0454664:Countries [Geographic Area]
   770   C1441547:Derived [Qualitative Concept]
   770   C1705493:Western [Spatial Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.20: Results: CA were detected by CG (CG_CA) in 44 (29.3%) of the 150 patients and by FISH (FISH_CA) in 59 (67%) of the 88 patients studied. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: ":"

Phrase: "CA"

Phrase: "were"

Phrase: "detected by CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "in 44"

Phrase: "(29.3%"

Phrase: ")"

Phrase: "of the 150 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and by FISH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
           fluorescence hybridization situ
   833   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   790   C0444498:In situ [Spatial Concept]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0020202:Hybridisation [Genetic Function]
   753   C1300517:Hybridization [Laboratory Procedure]
   753   C1515981:And [Idea or Concept]

Phrase: "(FISH_CA) in 59"

Phrase: "(67%"

Phrase: ")"

Phrase: "of the 88 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.21: Presence of either CG_CA or FISH_CA was associated with a poor prognosis. 

Phrase: "Presence of either CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "FISH_CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "associated with a poor prognosis."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0278252:Poor prognosis [Finding]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0032854:Poor [Group Attribute]
   760   C0033325:Prognosis [Health Care Activity]
   760   C0542537:Poor [Qualitative Concept]
   760   C2700379:Poor [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.22: Patients with CG_CA and hyperdiploid chromosomes, always associated with several trisomies, had a longer survival (median 25 months versus 12 months; P=0.025) in comparison with those with non-hyperdiploid chromosomes, usually associated with a monosomy 13/partial deletion of 13q (13) and a rearrangement of 14q32. 

Phrase: "Patients with CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "hyperdiploid chromosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "associated with several trisomies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0041107:Trisomies [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "had"

Phrase: "a longer survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "(median 25 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "versus"

Phrase: "12 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "; P=0.025"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with those with non-hyperdiploid chromosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008633:Chromosomes [Cell Component]

Phrase: "usually"

Phrase: "associated with a monosomy 13/partial deletion of 13q"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   781   C0265451:partial monosomy 13q [Disease or Syndrome]
           monosomy 13q
   781   C2930905:Monosomy 13q, partial [Cell or Molecular Dysfunction]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1513478:Monosomy 13 [Cell or Molecular Dysfunction]
   762   C0008628:Partial Monosomy [Cell or Molecular Dysfunction]
   762   C2930745:Partial Monosomy [Cell or Molecular Dysfunction]
   762   C2930913:Deletion 13q [Cell or Molecular Dysfunction]
           Monosomy 13q
   742   C0026499:Monosomy [Congenital Abnormality]
   742   C0728938:Partial [Quantitative Concept]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1520537:13q [Nucleotide Sequence]
   742   C1550516:partial [Idea or Concept]
   742   C1880274:Deletion [Activity]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "a rearrangement of 14q32."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511695:Rearrangement [Genetic Function]
Processing 00000000.tx.23: A novel recurrent CG_CA, add(19)(p13), was found in four patients: all males with immunoglobulin G/ isotypes, extramedullary myeloma at diagnosis and a poor prognosis. 

Phrase: "A novel recurrent CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "found in four patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0150312:Found [Quantitative Concept]
   770   C0205450:Four [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: ":"

Phrase: "all males with immunoglobulin G/ isotypes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0024554:Males [Finding]
   753   C0086582:Males [Population Group]
   719 E C1706180:Male [Qualitative Concept]
   719 E C1706428:Male [Qualitative Concept]
   719 E C1706429:Male [Organism Attribute]

Phrase: "extramedullary myeloma at diagnosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026764:Myeloma [Neoplastic Process]
   770   C3538749:Myeloma [Intellectual Product]

Phrase: "and"

Phrase: "a poor prognosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0278252:Poor prognosis [Finding]
   861   C0033325:Prognosis [Health Care Activity]
Processing 00000000.tx.24: Three groups of patients with significantly different survival, CG_13, FISH_13 but without CG_13, and neither CG_13 nor FISH_13 (median 9 versus 15 versus 32 months; P=0.013) were identified. 

Phrase: "Three groups of patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "with significantly different survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]

Phrase: "CG_13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "but without CG_13,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   770   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "neither CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "nor"

Phrase: "FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(median 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0549183:Median [Spatial Concept]
   861   C0876920:Median [Quantitative Concept]
   861   C2347635:Median [Quantitative Concept]
   861   C2348144:Median [Quantitative Concept]
   861   C2939193:Median [Spatial Concept]

Phrase: "versus"

Phrase: "15"

Phrase: "versus"

Phrase: "32 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "; P=0.013"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.25: Conclusions: We conclude that MM CA in our patients are similar to those noted in Western countries, and that combined CG and FISH analysis can predict prognosis. 

Phrase: "Conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: ":"

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that MM CA in our patients"

Phrase: "are"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "noted in Western countries,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0454664:Countries [Geographic Area]
   770   C1705493:Western [Spatial Concept]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "and"

Phrase: "that combined CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "FISH analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "can"

Phrase: "predict"

Phrase: "prognosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]
Processing 00000000.tx.26: The clinical significance of add(19)(p13) needs to be further investigated. 

Phrase: "The clinical significance of add(19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C2826293:Clinical Significance [Finding]
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.27: Key words: cytogenetics, fluorescence in situ hybridization, multiple myeloma, prognosis  Introduction Top Abstract Introduction Patients and methods Results Discussion References  Multiple myeloma (MM) is a genetically unstable malignancy of postgerminal center B-lineage cells [1]. 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "cytogenetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "fluorescence in situ hybridization,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "multiple myeloma,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "prognosis  Introduction Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "(MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "a genetically unstable malignancy of postgerminal center B-lineage cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0006826:Malignancy [Neoplastic Process]
   739   C1306459:Malignancy [Finding]
   722   C0334227:Malignant cells [Cell]
   722   C2698007:Malignant Cells, NOS [Laboratory Procedure]

Phrase: "[1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "]."
Processing 00000000.tx.28: Using conventional cytogenetics (CG) and interphase fluorescence in situ hybridization (FISH), with other modern cytogenetic techniques, it has now been established that aneuploidy with chromosome abnormalities (CA) is almost universal in MM [24]. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conventional cytogenetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "(CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "and"

Phrase: "interphase fluorescence in situ hybridization"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "with other modern cytogenetic techniques,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0752095:Cytogenetic Techniques [Molecular Biology Research Technique]
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]

Phrase: "it"

Phrase: "has"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that aneuploidy with chromosome abnormalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002938:Aneuploidy [Cell or Molecular Dysfunction]

Phrase: "(CA)"

Phrase: "is"

Phrase: "almost universal in MM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0173021:Universal [Biomedical or Dental Material,Carbohydrate]
   760   C0175671:Universal [Qualitative Concept]
   760   C1552870:Universal [Idea or Concept]

Phrase: "[24"

Phrase: "]."
Processing 00000000.tx.29: Almost all CA in MM involve complex numeric and structural changes [2, 5]. 

Phrase: "Almost"

Phrase: "all CA in MM"

Phrase: "involve"

Phrase: "complex numeric"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237753:Numeric [Quantitative Concept]
   861   C1548313:Numeric [Idea or Concept]
   861   C1704455:Numeric [Qualitative Concept]

Phrase: "and"

Phrase: "structural changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0678594:Structural [Spatial Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "]."
Processing 00000000.tx.30: Common numeric changes in MM are trisomies involving chromosomes 3, 5, 7, 9, 11, 15, 19 and 21, and monosomies involving chromosomes 8, 13, 16, 17, 22 and Y [2, 5, 6]. 

Phrase: "Common numeric changes in MM"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "trisomies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041107:Trisomies [Disease or Syndrome]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "chromosomes 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0008666:Chromosome 3 [Cell Component]
   861   C0008633:Chromosomes [Cell Component]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "9,"

Phrase: "11,"

Phrase: "15,"

Phrase: "19"

Phrase: "and"

Phrase: "21,"

Phrase: "and"

Phrase: "monosomies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026499:Monosomies [Congenital Abnormality]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "chromosomes 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0008671:Chromosome 8 [Cell Component]
   861   C0008633:Chromosomes [Cell Component]

Phrase: "13,"

Phrase: "16,"

Phrase: "17,"

Phrase: "22"

Phrase: "and"

Phrase: "Y [2,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: "]."
Processing 00000000.tx.31: Common structural changes in CA include rearrangements of 14q32, partial deletion of chromosome 13, duplications of 1q and deletions of 1p, 6q, 11q and 17p [1, 5, 7]. 

Phrase: "Common structural changes in CA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0678594:Structural [Spatial Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "rearrangements of 14q32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511695:Rearrangements [Genetic Function]

Phrase: "partial deletion of chromosome 13,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "duplications of 1q"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0332597:duplications [Functional Concept]
   756 E C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "deletions of 1p,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   841   C0795796:Deletion 1p [Disease or Syndrome]
   790   C1880274:Deletions [Activity]
   756 E C1442161:Deletion [Cell or Molecular Dysfunction]
   756 E C1511760:Deletion [Genetic Function]

Phrase: "6q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521554:6q [Nucleotide Sequence]

Phrase: "11q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0796366:11q [Nucleotide Sequence]

Phrase: "and"

Phrase: "17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: "[1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: "]."
Processing 00000000.tx.32: Some CA in MM are not randomly distributed, but are tightly associated and may be responsible for the variability of MM with respect to the natural history, morphological and immunological features of myeloma cells and clinical status [5, 6, 8, 9]. 

Phrase: "Some CA in MM"

Phrase: "are"

Phrase: "not randomly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "are"

Phrase: "tightly"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the variability of MM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "with respect to the natural history,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0175860:Natural History [Occupation or Discipline]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0205296:Natural [Functional Concept]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "morphological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0543482:morphological [Spatial Concept]
   928 E C0332437:Morphology [Qualitative Concept]
   928 E C0700329:Morphology, NOS [Finding]
   928 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "immunological features of myeloma cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1562749:Cell feature [Organism Attribute]
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "clinical status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449440:Clinical status [Qualitative Concept]
   861   C0449438:Status [Qualitative Concept]

Phrase: "[5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "8,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.33: Two aneuploidy groups of MM, hyperdiploid and non-hyperdiploid MM, have been proposed based on chromosome numbers [10, 11]. 

Phrase: "Two aneuploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002938:Aneuploidy [Cell or Molecular Dysfunction]

Phrase: "groups of MM,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   770   C0439064:Multiple [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C3538749:Myeloma [Intellectual Product]

Phrase: "hyperdiploid"

Phrase: "and"

Phrase: "non-hyperdiploid MM,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   812   C0439064:Multiple [Quantitative Concept]
   812   C3538749:Myeloma [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "based on chromosome numbers"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   802   C2981742:Base Number [Conceptual Entity]
   799   C1953343:Chromosome number [Cell]
   770   C0008633:Chromosome [Cell Component]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "[10,"

Phrase: "11"

Phrase: "]."
Processing 00000000.tx.34: These two ploidy subcategories are associated with distinct clinical presentation and outcome [1012]. 

Phrase: "These two ploidy subcategories"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1515010:Subcategory [Classification]

Phrase: "are"

Phrase: "associated with distinct clinical presentation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C2708283:Clinical presentation [Intellectual Product]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0449450:Presentation [Idea or Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "[1012"

Phrase: "]."
Processing 00000000.tx.35: Analogous to acute and chronic leukemias, such CA of MM represent not only the biological basis of the clinical heterogeneity, but also the prognostic parameters [13]. 

Phrase: "Analogous to acute"

Phrase: "and"

Phrase: "chronic leukemias,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1279296:chronic leukemias [Neoplastic Process]
   861   C0023418:LEUKEMIAS, NOS [Neoplastic Process]

Phrase: "such CA of MM"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "the biological basis of the clinical heterogeneity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "but"

Phrase: "also"

Phrase: "the prognostic parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "[13"

Phrase: "]."
Processing 00000000.tx.36: Hypodiploidy and deletion of chromosome 13, including monosomy 13 and partial deletion of 13q (13), could be used as negative prognostic predictors for MM patients receiving either conventional chemotherapy [12, 1416] or high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) [1721]. 

Phrase: "Hypodiploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333691:Hypodiploidy [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "deletion of chromosome 13,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "monosomy 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513478:Monosomy 13 [Cell or Molecular Dysfunction]
   861   C0026499:Monosomy [Congenital Abnormality]

Phrase: "and"

Phrase: "partial deletion of 13q"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2930913:Deletion 13q [Cell or Molecular Dysfunction]
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "could"

Phrase: "be"

Phrase: "used as negative prognostic predictors"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0205160:Negative [Qualitative Concept]
   760   C0220901:prognostic [Intellectual Product]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   726   C2698872:Predictor [Idea or Concept]

Phrase: "for MM patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0026764:Multiple Myeloma [Neoplastic Process]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "either conventional chemotherapy"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0013217:chemotherapy [Functional Concept]
   827   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0439858:Conventional [Qualitative Concept]
   755 E C0086047:convention [Human-caused Phenomenon or Process]

Phrase: "[12,"

Phrase: "1416"

Phrase: "]"

Phrase: "or"

Phrase: "high-dose chemotherapy"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1328050:high-dose chemotherapy [Therapeutic or Preventive Procedure]
   901   C0444956:High dose [Quantitative Concept]
   827   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0013217:chemotherapy [Functional Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]

Phrase: "followed by autologous hematopoietic stem cell transplantation (auto-HSCT)"
Meta Candidates (Total=25; Excluded=1; Pruned=0; Remaining=24)
   897   C1831743:autologous hematopoietic stem cell transplantation [Therapeutic or Preventive Procedure]
           Autologous Stem Cell Transplantation
   853   C0472699:Hematopoietic Stem Cell Transplantation [Therapeutic or Preventive Procedure]
           Hematopoietic Cell Transplantation
   814   C0018956:Haematopoietic stem cell [Cell]
   814   C1504389:Stem Cell Transplantation [Therapeutic or Preventive Procedure]
   778   C0038250:Stem cell [Cell]
   778   C0206153:Cell Transplantation [Therapeutic or Preventive Procedure]
   778   C0332283:Followed by [Temporal Concept]
           followed
   774   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   774   C2323499:Hematopoietic cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0018957:Haematopoietic [Body System]
   748   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040733:transplantation [Functional Concept]
   748   C0229601:Hematopoietic [Functional Concept]
   748   C0242767:Stem [Plant]
   748   C0439859:Autologous [Qualitative Concept]
   748   C1186763:Stem [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "[1721"

Phrase: "]."
Processing 00000000.tx.37: Other recurrent CA in MM, such as t(4;14), t(14;16), deletion of 17p13, abnormalities of 11q and 22q, monosomies of 2, 3, 14 and 19, and 1p deletions, are associated with a poor prognosis [6, 14, 16, 2224]. 

Phrase: "Other recurrent CA in MM,"

Phrase: "such as t(4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3641140:T-4 [Spatial Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ")"

Phrase: ","

Phrase: "t(14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";16"

Phrase: ")"

Phrase: ","

Phrase: "deletion of 17p13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442161:Deletion [Cell or Molecular Dysfunction]
   790   C1511760:Deletion [Genetic Function]
   790   C1880274:Deletion [Activity]

Phrase: "abnormalities of 11q"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0000768:Abnormalities [Congenital Abnormality]
   790   C0000769:abnormalities [Functional Concept]
   756 E C1704258:Abnormality [Finding]
   706 E C0205161:Abnormal [Qualitative Concept]
   706 E C2347472:% Abnormal [Quantitative Concept]
   706 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "22q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521100:22q [Nucleotide Sequence]

Phrase: "monosomies of 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026499:Monosomies [Congenital Abnormality]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "14"

Phrase: "and"

Phrase: "19,"

Phrase: "and"

Phrase: "1p deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "are"

Phrase: "associated with a poor prognosis"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0278252:Poor prognosis [Finding]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0032854:Poor [Group Attribute]
   760   C0033325:Prognosis [Health Care Activity]
   760   C0542537:Poor [Qualitative Concept]
   760   C2700379:Poor [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[6,"

Phrase: "14,"

Phrase: "16,"

Phrase: "2224"

Phrase: "]."
Processing 00000000.tx.38: Analysis of CA in MM patients is required to elucidate the pathogenesis of the disease, predict treatment outcome and possibly identify distinct groups of MM patients who could benefit from aggressive or novel therapies. 

Phrase: "Analysis of CA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "in MM patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0026764:Multiple Myeloma [Neoplastic Process]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the pathogenesis of the disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]

Phrase: "predict"

Phrase: "treatment outcome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085415:Treatment outcome [Qualitative Concept]
  1000   C0599860:treatment outcome [Qualitative Concept]
   861   C1274040:Outcome [Functional Concept]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "identify"

Phrase: "distinct groups of MM patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "who"

Phrase: "could"

Phrase: "benefit from aggressive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001807:aggressive [Mental or Behavioral Dysfunction]
   790   C0580822:Aggressive [Temporal Concept]
   790   C0814225:Benefit [Quantitative Concept]

Phrase: "or"

Phrase: "novel therapies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0087111:therapies [Therapeutic or Preventive Procedure]
   827 E C0039798:therapy [Functional Concept]
   827 E C1363945:Therapy [Finding]
Processing 00000000.tx.39: Uneven geographical distribution of non-random CA in malignant disorders has been reported previously [25, 26]. 

Phrase: "Uneven geographical distribution of non-random CA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]
   728   C0681686:Geographic Distribution [Temporal Concept]

Phrase: "in malignant disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "[25,"

Phrase: "26"

Phrase: "]."
Processing 00000000.tx.40: It was suggested that the heterogeneity in the incidence of non-random CA in various areas was a reflection of ethnic differences or environmental factors [27]. 

Phrase: "It"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the heterogeneity in the incidence of non-random CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "in various areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "was"

Phrase: "a reflection of ethnic differences"

Phrase: "or"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "[27"

Phrase: "]."
Processing 00000000.tx.41: We found that CA in Chinese lymphoma patients, in Taiwan, were different from those noted in lymphoma patients in Western countries [28]. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that CA in Chinese lymphoma patients,"

Phrase: "in Taiwan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "were"

Phrase: "different from those"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "noted in lymphoma patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   786   C2360554:Patient Note [Clinical Attribute]
   770   C0024299:Lymphoma [Neoplastic Process]
   770   C0030705:Patients [Patient or Disabled Group]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "in Western countries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454664:Countries [Geographic Area]

Phrase: "[28"

Phrase: "]."
Processing 00000000.tx.42: Indeed, the incidence of MM in Asia is much lower than that recorded in Western countries [29]. 

Phrase: "Indeed,"

Phrase: "the incidence of MM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "in Asia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003980:Asia [Geographic Area]
   928 E C0078988:Asian [Population Group]

Phrase: "is"

Phrase: "much lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "recorded in Western countries"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0454664:Countries [Geographic Area]
   770   C1705493:Western [Spatial Concept]
   737   C0034869:Record [Intellectual Product]

Phrase: "[29"

Phrase: "]."
Processing 00000000.tx.43: It is not clear whether this disparity in CA between Asia and Western countries also extends to CA characteristic of MM. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "this disparity in CA"

Phrase: "between Asia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003980:Asia [Geographic Area]
   928 E C0078988:Asian [Population Group]

Phrase: "and"

Phrase: "Western countries also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454664:Countries [Geographic Area]

Phrase: "extends to CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231448:Extend [Functional Concept]
   790   C0439792:extend [Spatial Concept]

Phrase: "characteristic of MM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.44: Therefore, we have used conventional cytogenetics and FISH to analyze CA and their clinical significance in 150 Chinese patients with newly diagnosed MM in Taiwan and compared our findings with those derived from Western countries.  

Phrase: "Therefore,"

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conventional cytogenetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "FISH to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "analyze"

Phrase: "CA"

Phrase: "and"

Phrase: "their clinical significance in 150 Chinese patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2826293:Clinical Significance [Finding]
   748   C0237881:Significance [Quantitative Concept]
   748   C0750502:Significance [Idea or Concept]

Phrase: "with newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "MM in Taiwan"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   770   C0439064:Multiple [Quantitative Concept]
   770   C3538749:Myeloma [Intellectual Product]

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "our findings with those"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "derived from Western countries."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0454664:Countries [Geographic Area]
   770   C1441547:Derived [Qualitative Concept]
   770   C1705493:Western [Spatial Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.45: Patients and methods Top Abstract Introduction Patients and methods Results Discussion References  Patients Between June 1986 and December 2003, 150 newly diagnosed and untreated MM patients with accessible cytogenetic results at our hospital were enrolled. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patients Between June 1986"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "December 2003,"

Phrase: "150 newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750546:newly [Idea or Concept]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "and"

Phrase: "untreated MM patients with accessible cytogenetic results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "at our hospital"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
  1000   C1510665:Hospital [Qualitative Concept]
   916 E C1609061:Hospitals [Intellectual Product]

Phrase: "were"

Phrase: "enrolled."
Processing 00000000.tx.46: In addition to the CG analysis, 88 patients had FISH performed simultaneously. 

Phrase: "In addition to the CG analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "88 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "simultaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.47: The work was approved by our institutional human ethics committee that oversees research involving human subjects. 

Phrase: "The work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "approved by our institutional human ethics committee"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0086471:Institutional Ethics Committee [Professional or Occupational Group]
   778   C0085546:Ethics Committee [Professional or Occupational Group]
   774   C0015003:Ethics, Institutional [Idea or Concept]
   748   C0015000:Ethics [Idea or Concept]
   748   C0086418:Human [Human]
   748   C0205540:Approved [Qualitative Concept]
   748   C1527243:ethics [Idea or Concept]
   748   C2699414:Committee [Group]

Phrase: "that"

Phrase: "oversees"

Phrase: "research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "human subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0178693:human subjects [Research Activity]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.48: Written informed consent was obtained from all patients. 

Phrase: "Written informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0021430:Informed Consent [Regulation or Law]
   827   C1511481:Consent [Functional Concept]
   827   C1522154:Informed [Qualitative Concept]
   827   C1554192:consent [Idea or Concept]
   793 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   793 E C0700287:inform [Health Care Activity]
   793 E C1552002:inform [Idea or Concept]

Phrase: "was"

Phrase: "obtained from all patients."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.49: Conventional cytogenetics Bone marrow (BM) samples were aspirated into heparinized syringes and CG with G-banding method was performed on BM cells after 13 days of unstimulated culture as described previously [26]. 

Phrase: "Conventional cytogenetics Bone marrow (BM) samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0438737:Bone marrow sample [Body Substance]
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "aspirated into heparinized syringes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0039142:Syringes [Medical Device]
   770   C0039147:Syringes [Anatomical Abnormality]
   770   C0700198:Aspirated [Pathologic Function]
   737 E C0278423:Syrinx [Body Part, Organ, or Organ Component]
   737 E C0370199:Aspirate [Body Substance]
   737 E C1706072:Syringe [Manufactured Object]

Phrase: "and"

Phrase: "CG with G-banding method"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "performed on BM cells"
Meta Candidates (Total=22; Excluded=9; Pruned=0; Remaining=13)
   862   C0005955:Bone Marrow Cells [Cell]
   806   C0005953:Bone Marrow [Tissue]
   797   C0222677:Bone cells [Cell]
   781 E C0029432:Bone cell [Cell]
   770 E C1708973:Medullary Bone [Tissue]
   760   C0007634:Cells [Cell]
   760   C0086590:Marrow [Food]
   760   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   760   C0376152:Marrow [Body Part, Organ, or Organ Component]
   760   C0391978:Bone [Tissue]
   760   C0884358:Performed [Functional Concept]
   760   C1266908:Bone [Body Part, Organ, or Organ Component]
   760   C1266909:Bone [Body System]
   760   C1546708:Marrow [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   704 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   704 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   704 E C1550278:Medullary [Body Part, Organ, or Organ Component]

Phrase: "after 13 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of unstimulated culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "[26"

Phrase: "]."
Processing 00000000.tx.50: CA and ploidy levels were defined according to International System for Human Cytogenetic Nomenclature [30]. 

Phrase: "CA"

Phrase: "and"

Phrase: "ploidy levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "defined according to International System"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0449913:System [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C1512888:International [Idea or Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "for Human Cytogenetic Nomenclature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0600281:Nomenclature [Intellectual Product]
   827   C1524067:Nomenclature [Intellectual Product]

Phrase: "[30"

Phrase: "]."
Processing 00000000.tx.51: For comparison with the results in other areas [10], patients were divided into two groups: one with hyperdiploid MM (4757 chromosomes) and the other with non-hyperdiploid MM including the hypodiploid (3545 chromosomes), pseudodiploid (46 chromosomes) and tri-/tetraploid MM (58103 chromosomes). 

Phrase: "For comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "in other areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205146:areas [Spatial Concept]
   966 E C0017446:Area [Geographic Area]

Phrase: "[10"

Phrase: "],"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "divided into two groups"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205448:Two [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "one with hyperdiploid MM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "(4757 chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "the other with non-hyperdiploid MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   804   C0439064:Multiple [Quantitative Concept]
   804   C3538749:Myeloma [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the hypodiploid"

Phrase: "(3545 chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "pseudodiploid"

Phrase: "(46 chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "tri-/tetraploid MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   812   C0439064:Multiple [Quantitative Concept]
   812   C3538749:Myeloma [Intellectual Product]

Phrase: "(58103 chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: ")."
Processing 00000000.tx.52: Complex CA was defined by more than two cytogenetic changes. 

Phrase: "Complex CA"

Phrase: "was"

Phrase: "defined by more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704788:Defined [Conceptual Entity]
   790   C3539106:Defined [Intellectual Product]

Phrase: "than two cytogenetic changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.53: Fluorescence in situ hybridization FISH analysis was performed as previously described [31]. 

Phrase: "Fluorescence in situ hybridization FISH analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0002778:Analysis [Laboratory Procedure]
   791   C0936012:Analysis [Research Activity]
   791   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "[31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.54: Deletion of 13q14 was determined by combined use of a retinoblastoma gene-1 probe LSIRB1 (Vysis, Downers Grove, IL, USA) and a reference chromosome 10 centromeric probe LPE010G (Cytocell Ltd, Banbury, UK) in dual-color. 

Phrase: "Deletion of 13q14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442161:Deletion [Cell or Molecular Dysfunction]
   790   C1511760:Deletion [Genetic Function]
   790   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "determined by combined use of a retinoblastoma gene-1 probe LSIRB1"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   756   C0079424:Retinoblastoma Gene [Gene or Genome]
   756   C1524063:Use of [Functional Concept]
   754   C0441088:Gene probe [Medical Device]
   754   C0694889:retinoblastoma 1 [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]
   738   C0035335:Retinoblastoma [Neoplastic Process]
   738   C0042153:use [Functional Concept]
   738   C0080113:RETINOBLASTOMA [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0182400:Probe [Medical Device]
   738   C0205195:Combined [Qualitative Concept]
   738   C0457083:Use [Functional Concept]
   738   C1704681:Probe [Gene or Genome]
   738   C1947944:Use [Intellectual Product]
   738   C2347609:Probe [Chemical Viewed Functionally]
   738   C3536729:Probe [Manufactured Object]
   738   C3540616:Retinoblastoma [Intellectual Product]
   704 E C0336789:Combine [Manufactured Object]

Phrase: "(Vysis,"

Phrase: "Downers Grove,"

Phrase: "IL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "a reference chromosome 10 centromeric probe LPE010G"

Phrase: "(Cytocell Ltd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136140:LTD [Organ or Tissue Function]

Phrase: "Banbury,"

Phrase: "UK"

Phrase: ")"

Phrase: "in dual-color."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0009393:Color [Natural Phenomenon or Process]
   861   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   861   C1705245:Color [Pharmacologic Substance]
   789 E C0522507:colored [Qualitative Concept]
Processing 00000000.tx.55: Deletion of 17p13, where the p53 gene was located, was determined by use of a LSIp53 probe (Vysis) combined with a chromosome 17 centromeric probe (Cytocell Ltd). 

Phrase: "Deletion of 17p13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442161:Deletion [Cell or Molecular Dysfunction]
   790   C1511760:Deletion [Genetic Function]
   790   C1880274:Deletion [Activity]

Phrase: "where"

Phrase: "the p53 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079419:p53 gene [Gene or Genome]
  1000   C1705526:p53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "located"

Phrase: ","

Phrase: "was"

Phrase: "determined by use of a LSIp53 probe"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0182400:Probe [Medical Device]
   748   C0457083:Use [Functional Concept]
   748   C1704681:Probe [Gene or Genome]
   748   C1947944:Use [Intellectual Product]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]

Phrase: "(Vysis"

Phrase: ")"

Phrase: "combined with a chromosome 17 centromeric probe"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0008659:Chromosome 17 [Cell Component]
   748   C0008633:Chromosome [Cell Component]
   748   C0182400:Probe [Medical Device]
   748   C0205195:Combined [Qualitative Concept]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "(Cytocell Ltd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136140:LTD [Organ or Tissue Function]

Phrase: ")."
Processing 00000000.tx.56: Several other centromeric probes, LPE003R, LPE007G, LPE011R and LPE018G (Cytocell Ltd), were used to detect trisomies/monosomies of chromosomes 3, 7, 11 and 18, respectively. 

Phrase: "Several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other centromeric probes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "LPE003R,"

Phrase: "LPE007G,"

Phrase: "LPE011R"

Phrase: "and"

Phrase: "LPE018G"

Phrase: "(Cytocell Ltd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136140:LTD [Organ or Tissue Function]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "trisomies/monosomies of chromosomes 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1709071:Monosomy 3 [Cell or Molecular Dysfunction]
   760   C0026499:Monosomies [Congenital Abnormality]

Phrase: "7,"

Phrase: "11"

Phrase: "and"

Phrase: "18,"

Phrase: "respectively."
Processing 00000000.tx.57: To improve the specificity of the FISH analysis, we combined the FISH technique with immunofluorescence staining of the cytoplasmic light chain of plasma cell (PC) (cIg-FISH; anti-human kappa and anti-human lambda probes, conjugated with 7-amino-4-methylcourmarin-3-acetic acid; Vector Laboratories, Burlingame, CA, USA) as described previously [32]. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "the specificity of the FISH analysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0037791:Specificity [Quantitative Concept]
   742   C1511884:Specificity [Quantitative Concept]

Phrase: "we"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "the FISH technique with immunofluorescence staining of the cytoplasmic light chain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   747   C0016318:Immunofluorescence Technique [Laboratory Procedure]
   734   C0449851:Technique [Functional Concept]
   719 E C0282649:Immunofluorescence Technique, Direct [Laboratory Procedure]

Phrase: "of plasma cell (PC)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032112:Plasma cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1269647:Cell [Cell]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(cIg-FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "; anti-human kappa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439099:Kappa [Intellectual Product]

Phrase: "and"

Phrase: "anti-human lambda probes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: "conjugated with 7-amino-4-methylcourmarin-3-acetic acid"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   764   C0000985:Acetic acid [Organic Chemical]
   762   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0522529:Conjugated [Spatial Concept]
   742   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   708 E C0301869:Conjugate [Immunologic Factor]

Phrase: "; Vector Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "[32"

Phrase: "]."
Processing 00000000.tx.58: BM cells from five transplantation donors were used as normal controls. 

Phrase: "BM cells from five transplantation donors"
Meta Candidates (Total=26; Excluded=7; Pruned=0; Remaining=19)
   826   C1258861:bone cells marrow transplantation [Therapeutic or Preventive Procedure]
   814   C0005955:Bone Marrow Cells [Cell]
   804   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   804   C1313934:Bone marrow donors [Finding]
   789 E C0260787:bone donor marrow [Population Group]
   778   C0005953:Bone Marrow [Tissue]
   774   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   774   C0206153:cells transplantation [Therapeutic or Preventive Procedure]
   774   C0222677:Bone cells [Cell]
   774   C1313933:Bone donors [Finding]
   757 E C0029432:Bone cell [Cell]
   757 E C0260786:Bone donor [Population Group]
   748   C0007634:Cells [Cell]
   748   C0086590:Marrow [Food]
   748   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   748   C0376152:Marrow [Body Part, Organ, or Organ Component]
   748   C0391978:Bone [Tissue]
   748   C1266908:Bone [Body Part, Organ, or Organ Component]
   748   C1266909:Bone [Body System]
   748   C1546708:Marrow [Intellectual Product]
   748   C3282337:Cells [Cell]
   746 E C1708973:Medullary Bone [Tissue]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used as normal controls."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   799   C2705716:normal control [Qualitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0042153:use [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.59: Threshold levels for gain or loss of signals for each probe in cIg-FISH, which were set at the mean of normal controls plus three standard deviations, were as follows: 13q14 deletion, 1.8%; 

Phrase: "Threshold levels for gain"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C0449864:Threshold [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "loss of signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C2984840:SIGNAL LOSS [Functional Concept]
   790   C1517945:Loss [Quantitative Concept]

Phrase: "for each probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "in cIg-FISH,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "which"

Phrase: "were"

Phrase: "set at the mean of normal controls"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   748   C0036849:Set [Mental Process]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C0444504:Mean [Quantitative Concept]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]
   748   C2347086:% Normal [Quantitative Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   745   C2705716:normal control [Qualitative Concept]
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: "plus three standard deviations,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0871420:Standard deviation [Quantitative Concept]
   827   C1442989:Standard [Qualitative Concept]
   827   C2828392:Standard [Intellectual Product]
   793   C0012727:Deviation [Spatial Concept]
   793   C0205419:Deviation [Qualitative Concept]
   793   C1705236:Deviation [Finding]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "13q14 deletion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "1.8%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.60: 17p13 deletion, 2.4%;+3, 0.7%;+7, 2.0%;+11, 1.9%; 

Phrase: "17p13 deletion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "2.4%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";+3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "0.7%"

Phrase: ";+7,"

Phrase: "2.0%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";+11,"

Phrase: "1.9%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.61: and +18, 1.9%. 

Phrase: "and +"

Phrase: "18,"

Phrase: "1.9%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.62: However, we only regarded the findings of any abnormal signals in more than 10% of 100300 scored PC as true evidence for CA on the cIg-FISH analysis, in order to avoid false positives [11]. 

Phrase: "However,"

Phrase: "we only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "regarded"

Phrase: "the findings of any abnormal signals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C2826279:Abnormal Finding [Finding]
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "in more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 10%"

Phrase: "of 100300 scored PC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0032112:Plasma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0032105:Plasma [Body Substance]
   812   C1269647:Cell [Cell]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "as true evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "for CA"

Phrase: "on the cIg-FISH analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0936012:Analysis [Research Activity]
   799   C1524024:analysis [Functional Concept]
   734   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "avoid"

Phrase: "false positives"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0205557:false positives [Laboratory or Test Result]
   861   C0205237:False [Qualitative Concept]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "[11"

Phrase: "]."
Processing 00000000.tx.63: Treatment A total of 131 (87.3%) received chemotherapy with MP (melphalan 9 mg/m2 and prednisolone 60 mg/m2 daily orally on days 14) regimen every 46 weeks until plateau phase was achieved or the disease was refractory to the treatment. 

Phrase: "Treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "A total of 131"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]

Phrase: "(87.3%"

Phrase: ")"

Phrase: "received chemotherapy with MP (melphalan 9 mg/m2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   744   C0013217:chemotherapy [Functional Concept]
   744   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "prednisolone 60 mg/m2 daily orally on days 14"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   773   C1532575:mg/m2/day [Quantitative Concept]
   764   C1319266:mg/m2 [Quantitative Concept]
   745   C0439422:day mg [Quantitative Concept]
   745   C0439423:mg/day [Quantitative Concept]
   742   C0032950:prednisolone [Pharmacologic Substance,Steroid]
   742   C0332173:Daily [Temporal Concept]
       E   /day
   742   C0439228:days [Temporal Concept]
   742   C0439269:mg% [Quantitative Concept]
   742   C0442027:Orally [Spatial Concept]
   742   C0457242:m2 [Quantitative Concept]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   708 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "regimen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040808:Regimen [Therapeutic or Preventive Procedure]
  1000   C2945654:regimen [Intellectual Product]

Phrase: "every 46 weeks until plateau phase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0332174:Every week [Temporal Concept]
       E   /week
   753   C0439230:weeks [Temporal Concept]

Phrase: "was"

Phrase: "achieved"

Phrase: "or"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "refractory to the treatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205269:Refractory [Functional Concept]
Processing 00000000.tx.64: Owing to poor clinical status or hesitation, 19 patients (12.7%) did not receive chemotherapy. 

Phrase: "Owing to poor clinical status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0449440:Clinical status [Qualitative Concept]
   827   C0449438:Status [Qualitative Concept]

Phrase: "or"

Phrase: "hesitation,"

Phrase: "19 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(12.7%"

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "chemotherapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
  1000   C0013217:chemotherapy [Functional Concept]
  1000   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.65: A total of 71 patients (47.3%) with high tumor burden were treated with two to four cycles of combination chemotherapy of VAD [vincristine 0.4 mg/m2, continuous intravenous infusion (CIVF), days 14; doxorubicin, 9 mg/m2, CIVF, days 14; dexamethasone, 40 mg, CIVF, days 14 and 811] at an interval of 4 weeks. 

Phrase: "A total of 71 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "(47.3%"

Phrase: ")"

Phrase: "with high tumor burden"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1449699:Tumor Burden [Diagnostic Procedure]
   827   C2828008:Burden [Idea or Concept]

Phrase: "were"

Phrase: "treated with two"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0205448:Two [Quantitative Concept]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "to four cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "of combination chemotherapy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013218:Combination Chemotherapy [Therapeutic or Preventive Procedure]
  1000   C1521750:Combination Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0013217:chemotherapy [Functional Concept]
   861   C0205195:Combination [Qualitative Concept]
   861   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C1947911:Combination [Physical Object]

Phrase: "of VAD [vincristine 0.4 mg/m2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1319266:mg/m2 [Quantitative Concept]
   799   C0457242:m2 [Quantitative Concept]

Phrase: "continuous intravenous infusion (CIVF),"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C1511497:Continuous Intravenous Infusion [Therapeutic or Preventive Procedure]
   913   C0444889:Continuous infusion [Therapeutic or Preventive Procedure]
   901   C0021440:Intravenous infusion [Therapeutic or Preventive Procedure]
   901   C1272892:Intravenous infusion [Biomedical or Dental Material]
   901   C1621368:Intravenous Infusion [Functional Concept]
   827   C0348016:Intravenous [Spatial Concept]
   827   C0549178:Continuous [Idea or Concept]
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]
   755 E C0456391:Continuities [Temporal Concept]
   755 E C0595960:Continuity [Qualitative Concept]

Phrase: "days 14"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "; doxorubicin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013089:Doxorubicin [Antibiotic,Organic Chemical]

Phrase: "9 mg/m2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1319266:mg/m2 [Quantitative Concept]
   827   C0457242:m2 [Quantitative Concept]
   734   C0651569:9-MG [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "CIVF,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C1511497:Continuous Intravenous Infusion [Therapeutic or Preventive Procedure]
   913   C0444889:Continuous infusion [Therapeutic or Preventive Procedure]
   901   C0021440:Intravenous infusion [Therapeutic or Preventive Procedure]
   901   C1272892:Intravenous infusion [Biomedical or Dental Material]
   901   C1621368:Intravenous Infusion [Functional Concept]
   827   C0348016:Intravenous [Spatial Concept]
   827   C0549178:Continuous [Idea or Concept]
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]
   755 E C0456391:Continuities [Temporal Concept]
   755 E C0595960:Continuity [Qualitative Concept]

Phrase: "days 14"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "; dexamethasone,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "40 mg,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "CIVF,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C1511497:Continuous Intravenous Infusion [Therapeutic or Preventive Procedure]
   913   C0444889:Continuous infusion [Therapeutic or Preventive Procedure]
   901   C0021440:Intravenous infusion [Therapeutic or Preventive Procedure]
   901   C1272892:Intravenous infusion [Biomedical or Dental Material]
   901   C1621368:Intravenous Infusion [Functional Concept]
   827   C0348016:Intravenous [Spatial Concept]
   827   C0549178:Continuous [Idea or Concept]
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]
   755 E C0456391:Continuities [Temporal Concept]
   755 E C0595960:Continuity [Qualitative Concept]

Phrase: "days 14"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "811"

Phrase: "]"

Phrase: "at an interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1272706:Interval [Temporal Concept]
  1000   C1552654:Interval [Idea or Concept]
  1000   C1552713:Interval [Intellectual Product]

Phrase: "of 4 weeks."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.66: High-dose chemotherapy (melphalan 200 mg/m2) followed by auto-HSCT was administered to 10 patients. 

Phrase: "High-dose chemotherapy"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1328050:high-dose chemotherapy [Therapeutic or Preventive Procedure]
   901   C0444956:High dose [Quantitative Concept]
   827   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0013217:chemotherapy [Functional Concept]
   827   C0178602:Dose [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]

Phrase: "(melphalan 200 mg/m2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1319266:mg/m2 [Quantitative Concept]
   812   C0457242:m2 [Quantitative Concept]

Phrase: ")"

Phrase: "followed by auto-HSCT"
Meta Candidates (Total=25; Excluded=1; Pruned=0; Remaining=24)
   897   C1831743:autologous hematopoietic stem cell transplantation [Therapeutic or Preventive Procedure]
           Autologous Stem Cell Transplantation
   853   C0472699:Hematopoietic Stem Cell Transplantation [Therapeutic or Preventive Procedure]
           Hematopoietic Cell Transplantation
   814   C0018956:Haematopoietic stem cell [Cell]
   814   C1504389:Stem Cell Transplantation [Therapeutic or Preventive Procedure]
   778   C0038250:Stem cell [Cell]
   778   C0206153:Cell Transplantation [Therapeutic or Preventive Procedure]
   778   C0332283:Followed by [Temporal Concept]
           followed
   774   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   774   C2323499:Hematopoietic cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0018957:Haematopoietic [Body System]
   748   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   748   C0040733:transplantation [Functional Concept]
   748   C0229601:Hematopoietic [Functional Concept]
   748   C0242767:Stem [Plant]
   748   C0439859:Autologous [Qualitative Concept]
   748   C1186763:Stem [Body Part, Organ, or Organ Component]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "was"

Phrase: "administered to 10 patients."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1521801:Administered [Functional Concept]
   737 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.67: Treatment response Treatment response criteria were as described previously [33, 34]. 

Phrase: "Treatment response Treatment response criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "[33,"

Phrase: "34"

Phrase: "]."
Processing 00000000.tx.68: In brief, responders included patients who had achieved a complete response, partial response or minimal response. 

Phrase: "In brief, responders"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "had"

Phrase: "achieved"

Phrase: "a complete response,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0677874:Complete Response [Finding]
   861   C0205197:Complete [Qualitative Concept]
   861   C0725685:COMPLEAT [Food]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
   789 E C0439812:Completeness [Qualitative Concept]

Phrase: "partial response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1521726:partial response [Finding]
   861   C0728938:Partial [Quantitative Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1550516:partial [Idea or Concept]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "minimal response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.69: Non-responders included the patients who had no response or had progressive disease. 

Phrase: "Non-responders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "had"

Phrase: "no response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "had"

Phrase: "progressive disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0677932:progressive disease [Neoplastic Process]
  1000   C1335499:Progressive Disease [Finding]
  1000   C3539781:Progressive Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0205329:Progressive [Functional Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.70: Overall survival (OS) was defined as the time period from the date of diagnosis to the date of death, regardless of cause. 

Phrase: "Overall survival (OS)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C0282416:Overall [Intellectual Product]
   861   C1561607:Overall [Qualitative Concept]

Phrase: "was"

Phrase: "defined as the time period"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0439582:Time period [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0439531:/period [Temporal Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C1948053:Period [Temporal Concept]
   760   C3539106:Defined [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "from the date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "of diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "to the date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "of death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "regardless of cause."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.71: Statistical analysis 2 or Fisher's exact tests were used for between-group comparison of the discrete variables. 

Phrase: "Statistical analysis 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0038215:Statistical [Occupation or Discipline]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "or"

Phrase: "Fisher's exact tests"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Tests [Laboratory Procedure]
   827   C0325045:Fisher [Mammal]
   827   C0392366:Tests [Intellectual Product]
   827   C2828393:Exact [Qualitative Concept]
   793 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "used for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "between-group comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "of the discrete variables."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]
Processing 00000000.tx.72: Two-sample t-test was used for between-group comparison of the means. 

Phrase: "Two-sample t-test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "used for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "between-group comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "of the means."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.73: KaplanMeier survival curves were used for estimation of OS. 

Phrase: "KaplanMeier survival curves"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   793   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "used for estimation of OS."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   767   C1524063:Use of [Functional Concept]
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
   753   C0282416:Overall [Intellectual Product]
   753   C0680844:estimation [Mental Process]
   753   C0681916:Estimation [Quantitative Concept]
   753   C0750572:Estimation [Quantitative Concept]
   753   C1273517:used [Finding]
   753   C1561607:Overall [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.74: Log-rank test was used to test for differences in OS between groups. 

Phrase: "Log-rank test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C0699794:Rank [Intellectual Product]
   827   C1708728:Log [Intellectual Product]
   827   C2986775:log [Occupational Activity]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for differences"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in OS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C0282416:Overall [Intellectual Product]
   861   C1561607:Overall [Qualitative Concept]

Phrase: "between groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.75: Several salient clinical and laboratory variables, including age, sex, disease stage, BM plasmacytosis, M-component isotype, levels of hemoglobin (Hb), white blood cell (WBC), platelet (PLA), lactate dehydrogenase (LDH), calcium (Ca), creatinine (Cr), C-reactive protein (CRP) and 2-microglobulin (2M) were assessed in all patients at diagnosis to determine its possible association with CA. 

Phrase: "Several salient clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "laboratory variables,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "disease stage,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0699749:disease stage [Diagnostic Procedure]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "BM plasmacytosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0238803:BONE MARROW PLASMACYTOSIS [Finding]
   827   C0085663:Plasmacytosis [Disease or Syndrome]
   734   C0005953:Bone Marrow [Tissue]

Phrase: "M-component isotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C0030490:M component [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "levels of hemoglobin (Hb),"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0019029:haemoglobin levels [Laboratory or Test Result]
   858   C1314664:haemoglobin levels [Laboratory Procedure]
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "white blood cell (WBC),"
Meta Candidates (Total=21; Excluded=8; Pruned=0; Remaining=13)
  1000   C0023516:White blood cell [Cell]
           White Cell
   901   C0005773:Blood cell [Cell]
   873 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007457:White [Population Group]
   827   C0007634:Cell [Cell]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]
   827   C0229664:Blood [Body Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "platelet (PLA),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005821:Platelet [Cell]
   916 E C1963076:Platelets [Finding]

Phrase: "lactate dehydrogenase (LDH),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "calcium (Ca),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "creatinine (Cr),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010294:Creatinine [Biologically Active Substance,Organic Chemical]
  1000   C1561535:Creatinine [Finding]

Phrase: "C-reactive protein (CRP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1879974:C-Reactive Protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "2-microglobulin (2M)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979927:Microglobulin [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "assessed in all patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1555289:Assessed Patient [Intellectual Product]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1516048:Assessed [Activity]

Phrase: "at diagnosis to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "determine"

Phrase: "its possible association with CA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
Processing 00000000.tx.76: All the variables and the CA were examined for their prognostic values on OS. 

Phrase: "All"

Phrase: "the variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:variables [Qualitative Concept]

Phrase: "and"

Phrase: "the CA"

Phrase: "were"

Phrase: "examined for their prognostic values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0042295:Values [Qualitative Concept]
   760   C0220901:prognostic [Intellectual Product]
   760   C0332128:Examined [Finding]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "on OS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C0282416:Overall [Intellectual Product]
   861   C1561607:Overall [Qualitative Concept]
Processing 00000000.tx.77: Those factors with statistically prognostic significance from univariate analysis were tested by multivariate analysis with the Cox proportional hazards regression model using forward stepwise selection. 

Phrase: "Those factors with statistically prognostic significance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1514474:Prognostic Factor [Clinical Attribute]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "from univariate analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683962:univariate analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "tested by multivariate analysis"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0026777:Multivariate Analysis [Quantitative Concept]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0392366:tested [Intellectual Product]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "with the Cox proportional hazards regression model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C0033489:Proportional Hazards Model [Intellectual Product,Quantitative Concept]
   853   C0018623:Model, Hazards [Intellectual Product,Quantitative Concept]
   804   C3161035:Model [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "forward stepwise selection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036576:selection [Genetic Function]
Processing 00000000.tx.78: In these prognostic analyses, continuous variables were categorized by the cut-off values as follows: age 60 years, DurieSalmon stage III, BM plasmacytosis 30%, IgA isotype, Hb <10 g/dl, WBC <4 x 109/l, PLA <1.5 x 1011/l, LDH 465 IU/l, Ca 2.4 mol/l, Cr 2 mg/dl, CRP 4 mg/dl and 2M 2.5 mg/l, as set up in previous reports [18, 20]. 

Phrase: "In these prognostic analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "continuous variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "were"

Phrase: "categorized by the cut-off values"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1442160:Cutoff [Functional Concept]
   753   C0000925:Cut [Injury or Poisoning]
   753   C0042295:Values [Qualitative Concept]
   753   C0871968:categorized [Activity]
   753   C1883724:CUT [Phenomenon or Process]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "age 60 years,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510829:Age-Years [Temporal Concept]
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "DurieSalmon stage III,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441771:Stage III [Intellectual Product]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "BM plasmacytosis 30%,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   923   C0238803:BONE MARROW PLASMACYTOSIS [Finding]
   861   C0005953:Bone Marrow [Tissue]
   812   C0085663:Plasmacytosis [Disease or Syndrome]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]

Phrase: "IgA isotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "<10 g/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439267:g/dL [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]

Phrase: "WBC"
Meta Candidates (Total=21; Excluded=8; Pruned=0; Remaining=13)
  1000   C0023516:White blood cell [Cell]
           White Cell
   901   C0005773:Blood cell [Cell]
   873 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007457:White [Population Group]
   827   C0007634:Cell [Cell]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]
   827   C0229664:Blood [Body Substance]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "<4 x 109/l,"

Phrase: "PLA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005821:Platelet [Cell]
   916 E C1963076:Platelets [Finding]

Phrase: "<1.5 x 1011/l,"

Phrase: "LDH 465 IU/l,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C0022917:LACTATE DEHYDROGENASE L [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0439457:IU/L [Quantitative Concept]

Phrase: "Ca 2.4 mol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0347982:mol/L [Quantitative Concept]

Phrase: "Cr 2 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "CRP 4 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "2M 2.5 mg/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439268:mg/L [Quantitative Concept]

Phrase: "as"

Phrase: "set up in previous reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "[18,"

Phrase: "20"

Phrase: "]."
Processing 00000000.tx.79: All directional P values were two-tailed, with a P value of 0.05 considered significant for all tests. 

Phrase: "All directional P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C1709380:P-Value [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "two-tailed,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039259:tailed [Body Part, Organ, or Organ Component]
   861   C0205448:Two [Quantitative Concept]

Phrase: "with a P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "of 0.05 considered significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0237881:significant [Quantitative Concept]
   812   C0750502:Significant [Idea or Concept]
   812   C1546944:Significant [Qualitative Concept]

Phrase: "for all tests."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0022885:Tests [Laboratory Procedure]
  1000   C0392366:Tests [Intellectual Product]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.80: All analyses were performed using SPSS 8.0 software (SPSS, Inc., Chicago, IL, USA).  

Phrase: "All analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SPSS 8.0 software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(SPSS,"

Phrase: "Inc.,"

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.81: Results Top Abstract Introduction Patients and methods Results Discussion References  Patient characteristics There were 98 males and 52 females, with a median age of 62 years (range 2488). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patient characteristics There"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0815172:patient characteristics [Clinical Attribute]
   827   C1521970:Characteristics [Qualitative Concept]

Phrase: "were"

Phrase: "98 males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "52 females,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0015780:Females [Finding]
   861   C0086287:Females [Population Group]
   827 E C0043210:female [Population Group]
   827 E C1705497:Female [Qualitative Concept]
   827 E C1705498:Female [Qualitative Concept]

Phrase: "with a median age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "of 62 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(range 2488"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: The main bioclinical features are summarized in Table 1. 

Phrase: "The main bioclinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]

Phrase: "are"

Phrase: "summarized in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.83: Up to December 2004, the median follow-up time for the patients was 62 months. 

Phrase: "Up to December 2004,"

Phrase: "the median follow-up time for the patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0589120:Follow-up [Finding]
   770   C1522577:follow-up [Health Care Activity]
   770   C1704685:FOLLOW-UP [Intellectual Product]
   770   C3274571:FOLLOW-UP [Health Care Activity]
   744   C0040223:Time [Temporal Concept]
   744   C0332283:follow [Temporal Concept]
   744   C1719822:Follow [Intellectual Product]
   744   C3541383:Time [Temporal Concept]

Phrase: "was"

Phrase: "62 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.84: The median OS for all patients was 27 months. 

Phrase: "The median OS for all patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   748   C0282416:Overall [Intellectual Product]
   748   C1561607:Overall [Qualitative Concept]

Phrase: "was"

Phrase: "27 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.85: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.86: Patient characteristics and demographics  Prevalence and details of CA detected by CG Among the 150 newly diagnosed MM patients, CA were detected by CG (CG_CA) in 44 patients (29.3%; Table 2). 

Phrase: "Patient characteristics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0815172:patient characteristics [Clinical Attribute]
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "demographics  Prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033105:Prevalence [Quantitative Concept]
   861   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "details of CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1522508:Detail [Qualitative Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "detected by CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "Among the 150 newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750546:newly [Idea or Concept]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "MM patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0026764:Multiple Myeloma [Neoplastic Process]

Phrase: "CA"

Phrase: "were"

Phrase: "detected by CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "in 44 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(29.3%"

Phrase: "; Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: The prevalence of CA increased with progressing disease stage, being 14.3%, 29.6% and 31.2% in the patients with DurieSalmon stage I, II and III diseases, respectively. 

Phrase: "The prevalence of CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "increased with progressing disease stage,"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   806   C0699749:disease stage [Diagnostic Procedure]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205217:Increased [Quantitative Concept]
   760   C0205329:progressing [Functional Concept]
   760   C0205390:Stage [Temporal Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   751   C0277564:Acquired disease [Disease or Syndrome]
   726 E C1272688:progress [Functional Concept]
   726 E C1280477:Progress [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "being"

Phrase: "14.3%,"

Phrase: "29.6%"

Phrase: "and"

Phrase: "31.2% in the patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0450355:31 [Intellectual Product]

Phrase: "with DurieSalmon stage I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441766:Stage I [Intellectual Product]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "II"

Phrase: "and"

Phrase: "III diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.88: Of the 44 patients with CG_CA, 19 (43.2%) showed hyperdiploidy and 25 (56.8%) non-hyperdiploidy; 

Phrase: "Of the 44 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "19"

Phrase: "(43.2%"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "hyperdiploidy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1305143:Hyperdiploidy [Cell or Molecular Dysfunction]
   944 E C0032578:Polyploidies [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "25"

Phrase: "(56.8%"

Phrase: ")"

Phrase: "non-hyperdiploidy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1305143:Hyperdiploidy [Cell or Molecular Dysfunction]
   861   C1518422:Non [Functional Concept]
   805 E C0032578:Polyploidies [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.89: the latter included 11 (25%) hypodiploidy, 11 (25%) pseudodiploidy and three (6.8%) tri-/tetraploidy (Table 2). 

Phrase: "the latter"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "11"

Phrase: "(25%"

Phrase: ")"

Phrase: "hypodiploidy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333691:Hypodiploidy [Cell or Molecular Dysfunction]

Phrase: "11"

Phrase: "(25%"

Phrase: ")"

Phrase: "pseudodiploidy"

Phrase: "and"

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "(6.8%"

Phrase: ")"

Phrase: "tri-/tetraploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333694:Tetraploidy [Cell or Molecular Dysfunction]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.91: Cytogenetic data from 150 multiple myeloma patients  A total of five patients had numeric abnormalities only, nine had structural abnormalities only and the remaining 30 patients exhibited both numeric and structural abnormalities. 

Phrase: "Cytogenetic data from 150 multiple myeloma patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C2707520:Patient data [Intellectual Product]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "A total of five patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "had"

Phrase: "numeric abnormalities only,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "nine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205455:Nine [Quantitative Concept]

Phrase: "had"

Phrase: "structural abnormalities only"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "the remaining 30 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "both numeric"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237753:Numeric [Quantitative Concept]
  1000   C1548313:Numeric [Idea or Concept]
  1000   C1704455:Numeric [Qualitative Concept]

Phrase: "and"

Phrase: "structural abnormalities."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]
Processing 00000000.tx.92: Complex CA were found in 35 patients (79.5%) with a median of 12 changes per patient (range four to 24). 

Phrase: "Complex CA"

Phrase: "were"

Phrase: "found in 35 patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "(79.5%"

Phrase: ")"

Phrase: "with a median"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "of 12 changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "per patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(range four to 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205450:Four [Quantitative Concept]
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.93: Common numerical changes were trisomies 9 (+9, 18/44 or 40.9%), 15 (34.1%), 3 (25%), 7 (25%) and 19 (25%), and the monosomy 13 (13; 31.8%). 

Phrase: "Common numerical changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "trisomies 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0432411:Trisomy 9 [Disease or Syndrome]
   861   C0041107:Trisomies [Disease or Syndrome]

Phrase: "(+9,"

Phrase: "18/44"

Phrase: "or"

Phrase: "40.9%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "15"

Phrase: "(34.1%"

Phrase: ")"

Phrase: ","

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(25%"

Phrase: ")"

Phrase: ","

Phrase: "7"

Phrase: "(25%"

Phrase: ")"

Phrase: "and"

Phrase: "19"

Phrase: "(25%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the monosomy 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513478:Monosomy 13 [Cell or Molecular Dysfunction]
   861   C0026499:Monosomy [Congenital Abnormality]

Phrase: "(13"

Phrase: "; 31.8%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: At least one trisomy was found in 24 patients (24/44; 54.5%); 

Phrase: "At least one trisomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041107:Trisomy [Disease or Syndrome]

Phrase: "was"

Phrase: "found in 24 patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "(24/44"

Phrase: "; 54.5%"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.95: trisomies tended to occur in clusters, and 18 of these 24 patients had multiple trisomies (more than three trisomies) (Table 2). 

Phrase: "trisomies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041107:Trisomies [Disease or Syndrome]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in clusters,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   756   C1555715:Cluster [Idea or Concept]
   756   C1704332:Cluster [Quantitative Concept]

Phrase: "and"

Phrase: "18 of these 24 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "multiple trisomies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041107:Trisomies [Disease or Syndrome]

Phrase: "(more than three trisomies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0041107:Trisomies [Disease or Syndrome]
   770   C0205172:More [Functional Concept]
   770   C0205449:Three [Quantitative Concept]

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: The incidence of multiple trisomies was higher in hyperdiploid than non-hyperdiploid MM (84.2% versus 8.0%, P <0.001). 

Phrase: "The incidence of multiple trisomies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "was"

Phrase: "higher in hyperdiploid"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "than non-hyperdiploid MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   812   C0439064:Multiple [Quantitative Concept]
   812   C3538749:Myeloma [Intellectual Product]

Phrase: "(84.2%"

Phrase: "versus"

Phrase: "8.0%,"

Phrase: "P <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.97: The most frequent structural aberrations were duplications of 1q (16/44, 36.4%), followed by rearrangements involving 14q32 (29.5%), deletions of 1p (1p, 27.3%), rearrangements involving 11q13 (15.9%) or 11q23 (11.4%), abnormalities involving 8q24 (15.9%) and interstitial deletions of 6q (15.9%). 

Phrase: "The most frequent structural aberrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   729   C0443127:Aberrant [Qualitative Concept]

Phrase: "were"

Phrase: "duplications of 1q"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0332597:duplications [Functional Concept]
   756 E C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "(16/44,"

Phrase: "36.4%"

Phrase: ")"

Phrase: ","

Phrase: "followed by rearrangements"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1511695:Rearrangements [Genetic Function]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "14q32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520599:14q32 [Cell Component]

Phrase: "(29.5%"

Phrase: ")"

Phrase: ","

Phrase: "deletions of 1p"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   841   C0795796:Deletion 1p [Disease or Syndrome]
   790   C1880274:Deletions [Activity]
   756 E C1442161:Deletion [Cell or Molecular Dysfunction]
   756 E C1511760:Deletion [Genetic Function]

Phrase: "(1p,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327810:1p [Nucleotide Sequence]
  1000   C1552210:1p [Medical Device]

Phrase: "27.3%"

Phrase: ")"

Phrase: ","

Phrase: "rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511695:Rearrangements [Genetic Function]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "11q13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520381:11q13 [Cell Component]

Phrase: "(15.9%"

Phrase: ")"

Phrase: "or"

Phrase: "11q23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0796367:11q23 [Cell Component]

Phrase: "(11.4%"

Phrase: ")"

Phrase: ","

Phrase: "abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0000768:Abnormalities [Congenital Abnormality]
  1000   C0000769:abnormalities [Functional Concept]
   966 E C1704258:Abnormality [Finding]
   916 E C0205161:Abnormal [Qualitative Concept]
   916 E C2347472:% Abnormal [Quantitative Concept]
   916 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "8q24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515464:8q24 [Cell Component]

Phrase: "(15.9%"

Phrase: ")"

Phrase: "and"

Phrase: "interstitial deletions of 6q"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C0795816:Deletion 6q [Disease or Syndrome]
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "(15.9%"

Phrase: ")."
Processing 00000000.tx.98: CA involving chromosome regions where immunoglobulin light-chain genes were located, 2p11 () and 22q11 (), were noted in only one patient (2.3%) each. 

Phrase: "CA"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "chromosome regions where immunoglobulin light-chain genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   877   C0017352:Genes, Immunoglobulin Light Chain [Gene or Genome]
   845   C0017350:Genes, Immunoglobulin [Gene or Genome]
   795   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "located"

Phrase: ","

Phrase: "2p11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521169:2p11 [Cell Component]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "22q11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521101:22q11 [Cell Component]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "noted in only one patient"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C2360554:Patient Note [Clinical Attribute]
   760   C0030705:*^patient [Patient or Disabled Group]
   760   C0205171:Only [Quantitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "(2.3%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519042:2-3 [Research Activity]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "each."
Processing 00000000.tx.99: CA of chromosome 13 were observed in 23 patients, including 13 in 14 patients and partial deletion involving 13q14 in five patients; 

Phrase: "CA of chromosome 13"

Phrase: "were"

Phrase: "observed in 23 patients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0450348:23 [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "13 in 14 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "partial deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "13q14 in five patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1520544:13q14 [Cell Component]

Phrase: ";"
Processing 00000000.tx.100: thus, a total of 19 patients showed loss of chromosome 13q14 (Table 2). 

Phrase: "thus,"

Phrase: "a total of 19 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "loss of chromosome 13q14"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0598174:chromosome loss [Genetic Function]
   783 E C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]
   770   C1517945:Loss [Quantitative Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.101: With regards to abnormalities usually accompanied with other structural aberrations, 10 of the 19 patients had simultaneous 1q duplication, seven each had 14q32 rearrangements and 1p, and six each had 11q rearrangements and 17/17p13. 

Phrase: "With"

Phrase: "regards to abnormalities usually"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "accompanied with other structural aberrations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structural [Spatial Concept]

Phrase: "10 of the 19 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "simultaneous 1q duplication,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332597:Duplication [Functional Concept]
   827   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "each"

Phrase: "had"

Phrase: "14q32 rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "and"

Phrase: "1p,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327810:1p [Nucleotide Sequence]
  1000   C1552210:1p [Medical Device]

Phrase: "and"

Phrase: "six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "each"

Phrase: "had"

Phrase: "11q rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "and"

Phrase: "17/17p13."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520749:17p13 [Cell Component]
Processing 00000000.tx.102: Interestingly, the incidence of 13 or partial deletion of 13q (13) detected by the CG (CG_13) was more common in the non-hyperdiploid MM than in the hyperdiploid MM (56% versus 26.3%; P=0.049). 

Phrase: "Interestingly,"

Phrase: "the incidence of 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "or"

Phrase: "partial deletion of 13q"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2930913:Deletion 13q [Cell or Molecular Dysfunction]
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "(13"

Phrase: ")"

Phrase: "detected by the CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "was"

Phrase: "more common in the non-hyperdiploid MM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205214:Common [Quantitative Concept]
   744   C1522138:Common [Functional Concept]
   744   C3245511:common [Intellectual Product]

Phrase: "than"

Phrase: "in the hyperdiploid MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   827   C0439064:Multiple [Quantitative Concept]
   827   C3538749:Myeloma [Intellectual Product]

Phrase: "(56%"

Phrase: "versus"

Phrase: "26.3%"

Phrase: "; P=0.049"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.103: 14q32 rearrangements detected by the CG (CG_14q32) were observed in 13 patients (13/44; 29.5%), including four with t(11;14)(q13;q32), one with t(6;14)(p21;q32) and eight with add(14)(q32), in which the translocation partners of 14q32 could not be identified. 

Phrase: "14q32 rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "detected by the CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(CG_14q32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520599:14q32 [Cell Component]

Phrase: ")"

Phrase: "were"

Phrase: "observed in 13 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1441672:Observed [Functional Concept]

Phrase: "(13/44"

Phrase: "; 29.5%"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "four with t(11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205450:Four [Quantitative Concept]

Phrase: ";14"

Phrase: ")"

Phrase: "(q13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549864:Q13 [Intellectual Product]

Phrase: ";q32"

Phrase: ")"

Phrase: ","

Phrase: "one with t(6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: ";14"

Phrase: ")"

Phrase: "(p21"

Phrase: ";q32"

Phrase: ")"

Phrase: "and"

Phrase: "eight with add(14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205454:Eight [Quantitative Concept]
   770   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(q32"

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "the translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "partners of 14q32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0682323:Partner [Family Group]
   790   C1520599:14q32 [Cell Component]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.104: Similar to the CG_13, the incidence of CG_14q32 was also higher in the non-hyperdiploid MM than in the hyperdiploid MM (40% versus 15.8%; P=0.081). 

Phrase: "Similar to the CG_13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "the incidence of CG_14q32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "was"

Phrase: "also higher in the non-hyperdiploid MM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in the hyperdiploid MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   827   C0439064:Multiple [Quantitative Concept]
   827   C3538749:Myeloma [Intellectual Product]

Phrase: "(40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "versus"

Phrase: "15.8%"

Phrase: "; P=0.081"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.105: FISH is more sensitive than CG in detecting specific CA Data from the comparisons between CG and FISH in the detection of specific CA in the 88 patients who had both techniques simultaneously performed is shown in Table 3. 

Phrase: "FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "more sensitive than CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332324:Sensitive [Functional Concept]
   770   C1550474:sensitive [Idea or Concept]

Phrase: "in detecting specific CA Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "from the comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Comparison [Activity]

Phrase: "between CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "FISH in the detection of specific CA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
           fluorescence hybridization situ
   782   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   760   C0444498:In situ [Spatial Concept]
   739   C0016315:Fluorescence [Natural Phenomenon or Process]
   739   C0020202:Hybridisation [Genetic Function]
   739   C1300517:Hybridization [Laboratory Procedure]

Phrase: "in the 88 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "had"

Phrase: "both techniques simultaneously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "is"

Phrase: "shown in Table 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.106: CG_CA were noted in 23 patients (26.1%) and CA detected by FISH (FISH_CA) were noted in 59 patients (67%). 

Phrase: "CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "were"

Phrase: "noted in 23 patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   786   C2360554:Patient Note [Clinical Attribute]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0450348:23 [Quantitative Concept]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "(26.1%"

Phrase: ")"

Phrase: "and"

Phrase: "CA"

Phrase: "detected by FISH"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
           fluorescence hybridization situ
   833   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   790   C0444498:In situ [Spatial Concept]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0020202:Hybridisation [Genetic Function]
   753   C0442726:Detected [Finding]
   753   C1300517:Hybridization [Laboratory Procedure]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(FISH_CA)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "noted in 59 patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   786   C2360554:Patient Note [Clinical Attribute]
   770   C0030705:Patients [Patient or Disabled Group]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "(67%"

Phrase: ")."
Processing 00000000.tx.107: FISH_CA from three representative patients are shown in Figure 1. 

Phrase: "FISH_CA from three representative patients"

Phrase: "are"

Phrase: "shown in Figure 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.108: Interestingly, 40 of the 65 patients who did not have CG_CA showed FISH_CA. 

Phrase: "Interestingly,"

Phrase: "40 of the 65 patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0439509:/40 [Temporal Concept]
   760   C0450385:65 [Intellectual Product]

Phrase: "who"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "FISH_CA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.109: Deletion of 13q14 on FISH analysis (FISH_13) occurred in 30 patients. 

Phrase: "Deletion of 13q14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442161:Deletion [Cell or Molecular Dysfunction]
   790   C1511760:Deletion [Genetic Function]
   790   C1880274:Deletion [Activity]

Phrase: "on FISH analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "(FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "occurred in 30 patients."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1709305:Occurred [Activity]
   737 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.110: Notably, the FISH_13 was all monoallelic and present in all but one patient with CG_13. 

Phrase: "Notably,"

Phrase: "the FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "all monoallelic"

Phrase: "and"

Phrase: "present in all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "one patient with CG_13."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.111: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.112: Comparison of CG and FISH data  View larger version (118K): [in this window] [in a new window]  Figure 1. 

Phrase: "Comparison of CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "FISH data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(118K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.113: Combined fluorescence in situ hybridization (FISH) and immunofluorescence staining of the cytoplasmic light chain of interphase cells. 

Phrase: "Combined fluorescence in situ hybridization"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "immunofluorescence staining of the cytoplasmic light chain of interphase cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0487602:Staining [Laboratory Procedure]
   739   C1704680:Staining [Finding]
Processing 00000000.tx.114: The plasma cell was distinguishable by the intense blue fluorescence of the cytoplasm. 

Phrase: "The plasma cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032112:Plasma cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1269647:Cell [Cell]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "distinguishable by the intense blue fluorescence of the cytoplasm."
Processing 00000000.tx.115: (A) A plasma cell from a normal control showing two green signals for the centromeres of chromosome 10 (LPE010G) and two red signals for 13q14 (LSIRB1). 

Phrase: "(A)"

Phrase: "A plasma cell from a normal control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0491327:PLASMA, CONTROL, NORMAL [Indicator, Reagent, or Diagnostic Aid]
   778   C0032112:Plasma cell [Cell]
   774   C0007634:Normal cell [Cell]
           Cell
   774   C0440742:Normal plasma [Body Substance]
   774   C1268443:Normal cell [Cell]
   748   C0032105:Plasma [Body Substance]
   748   C1269647:Cell [Cell]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "two green signals for the centromeres of chromosome 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1710082:Signal [Phenomenon or Process]

Phrase: "(LPE010G"

Phrase: ")"

Phrase: "and"

Phrase: "two red signals for 13q14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "(LSIRB1"

Phrase: ")."
Processing 00000000.tx.116: The surrounding non-plasma cells do not have blue cytoplasmic staining. 

Phrase: "The surrounding non-plasma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0032112:Plasma Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "blue cytoplasmic staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
Processing 00000000.tx.117: (B) A plasma cell from a multiple myeloma (MM) patient with monosomy 13/partial deletion of chromosome 13q showing two green signals for the centromeres of chromosome 10 but only one red signal for 13q14. 

Phrase: "(B) A plasma cell from a multiple myeloma"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   793   C0026764:Myeloma, Plasma-Cell [Neoplastic Process]
   770   C0032112:Plasma cell [Cell]
   767   C0004561:B-cell [Cell]
   767   C0333843:Myeloma cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0032105:Plasma [Body Substance]
   744   C1269647:Cell [Cell]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "(MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ")"

Phrase: "patient with monosomy 13/partial deletion of chromosome 13q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030705:*^patient [Patient or Disabled Group]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "two green signals for the centromeres of chromosome 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1710082:Signal [Phenomenon or Process]

Phrase: "but"

Phrase: "only one red signal for 13q14."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.118: (C) A plasma cell from a MM patient without abnormality of chromosomes 11 and 18 showing two red signals for the centromeres of chromosome 11 (LPE011R) and two green signals for the centromeres of chromosome 18 (LPE018G). 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "A plasma cell from a MM patient"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0026764:Myeloma, Plasma-Cell [Neoplastic Process]
   770   C0032112:Plasma cell [Cell]
   767   C0333843:Myeloma cell [Cell]
   744   C0007634:Cell [Cell]
   744   C0032105:Plasma [Body Substance]
   744   C1269647:Cell [Cell]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "without abnormality"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704258:Abnormality [Finding]
   928 E C0205161:Abnormal [Qualitative Concept]
   928 E C2347472:% Abnormal [Quantitative Concept]
   928 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "of chromosomes 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0008653:Chromosome 11 [Cell Component]
   861   C0008633:Chromosomes [Cell Component]

Phrase: "and"

Phrase: "18"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "two red signals for the centromeres of chromosome 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1710082:Signal [Phenomenon or Process]

Phrase: "(LPE011R"

Phrase: ")"

Phrase: "and"

Phrase: "two green signals for the centromeres of chromosome 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1710082:Signal [Phenomenon or Process]

Phrase: "(LPE018G"

Phrase: ")."
Processing 00000000.tx.119: (D) A plasma cell from a MM patient with trisomy 11 showing two green signals for chromosome 18 but three red signals for chromosome 11 (x600 magnification; fluorescence microscope from Axioplan, Zeiss, Germany).  

Phrase: "(D) A plasma cell from a MM patient"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   784   C0026764:Myeloma, Plasma-Cell [Neoplastic Process]
   764   C0032112:Plasma cell [Cell]
   762   C0333843:Myeloma cell [Cell]
   762   C0524984:D Cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0032105:Plasma [Body Substance]
   742   C1269647:Cell [Cell]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "with trisomy 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0432409:Trisomy 11 [Congenital Abnormality]
   861   C0041107:Trisomy [Disease or Syndrome]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "two green signals for chromosome 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710082:Signal [Phenomenon or Process]

Phrase: "but"

Phrase: "three red signals for chromosome 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710082:Signal [Phenomenon or Process]

Phrase: "(x600 magnification"

Phrase: "; fluorescence microscope from Axioplan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0181839:Microscope [Medical Device]
   770   C1706379:Microscope [Medical Device]

Phrase: "Zeiss,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.120: Bioclinical features of patients with the CA The salient characteristics in the patients with CG_CA and those with normal karyotypes were compared and the results are presented in Table 1. 

Phrase: "Bioclinical features of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "with the CA"

Phrase: "The salient characteristics in the patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0815172:patient characteristics [Clinical Attribute]
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "with CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "those with normal karyotypes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   816   C0333684:Normal karyotype [Organism Attribute]
   816   C0863140:Normal karyotype [Finding]
   770   C0022526:karyotypes [Laboratory Procedure]
   770   C0178725:karyotypes [Laboratory or Test Result]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1261273:Karyotypes [Organism Attribute]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented in Table 1."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.121: Significantly, the patients with CG_CA had more plasma cells in the BM, lower PLA levels and higher incidence of extramedullary myeloma (extra-MM) at diagnosis. 

Phrase: "Significantly,"

Phrase: "the patients with CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "more plasma cells in the BM,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   804   C0005955:Bone Marrow Cells [Cell]
   788   C0545577:Marrow plasma cell [Cell]
   778   C0032112:Plasma Cells [Cell]
   774   C0222677:Bone cells [Cell]
   757 E C0029432:Bone cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0032105:Plasma [Body Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "PLA levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "higher incidence of extramedullary myeloma (extra-MM)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "at diagnosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.122: Among the 44 patients with CG_CA, the patients with CG_13 had lower Hb and PLA levels in comparison to other patients in this group (median 7.2 versus 9 g/dl, P=0.010; and 1.2 x 1011/l versus 1.7 x 1011/l, P=0.048, respectively). 

Phrase: "Among the 44 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "the patients with CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "lower Hb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PLA levels in comparison to other patients"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in this group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(median 7.2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0549183:Median [Spatial Concept]
   827   C0876920:Median [Quantitative Concept]
   827   C2347635:Median [Quantitative Concept]
   827   C2348144:Median [Quantitative Concept]
   827   C2939193:Median [Spatial Concept]

Phrase: "versus"

Phrase: "9 g/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439267:g/dL [Quantitative Concept]
   827   C3642216:/dL [Quantitative Concept]

Phrase: "P=0.010"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450300:0.010" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "and"

Phrase: "1.2 x 1011/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   911   C2348935:1/2 L [Quantitative Concept]

Phrase: "versus"

Phrase: "1.7 x 1011/l,"

Phrase: "P=0.048,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.123: The incidence of this abnormality was higher in patients with a subtype MM than in those with a subtype (83.3% versus 12%; P <0.001). 

Phrase: "The incidence of this abnormality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "was"

Phrase: "higher in patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "with a subtype MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   827   C0439064:Multiple [Quantitative Concept]
   827   C3538749:Myeloma [Intellectual Product]

Phrase: "than"

Phrase: "in those with a subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:Subtype [Classification]

Phrase: "(83.3%"

Phrase: "versus"

Phrase: "12%"

Phrase: "; P <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.124: Patients with CA involving 8q also had lower platelet levels but higher calcium levels in comparison with patients without this CA (median 0.9 x 1011/l versus 1.6 x 1011/l, P=0.007; and 2.8 versus 2.4 mol/l, P=0.035, respectively). 

Phrase: "Patients with CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "8q also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1515445:8q [Nucleotide Sequence]

Phrase: "had"

Phrase: "lower platelet levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "higher calcium levels in comparison"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0201925:calcium levels [Laboratory Procedure]
   806   C0428302:calcium levels [Laboratory or Test Result]
   790   C0553702:high calcium [Finding]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0441889:Levels [Qualitative Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "with patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "without this CA (median 0.9 x 1011/l"

Phrase: "versus"

Phrase: "1.6 x 1011/l,"

Phrase: "P=0.007"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "and"

Phrase: "2.8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "versus"

Phrase: "2.4 mol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0347982:mol/L [Quantitative Concept]

Phrase: "P=0.035,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.125: Patients with CA involving 1p were more likely to have soft tissue plasmacytomas in comparison with patients without this CA (38.9% versus 7.7%; P=0.021). 

Phrase: "Patients with CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "1p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327810:1p [Nucleotide Sequence]
  1000   C1552210:1p [Medical Device]

Phrase: "were"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "soft tissue plasmacytomas in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032131:Plasmacytomas [Neoplastic Process]

Phrase: "with patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "without this CA (38.9%"

Phrase: "versus"

Phrase: "7.7%"

Phrase: "; P=0.021"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.126: Interestingly, all four patients with 19p13 rearrangements, add(19)(p13), were males. 

Phrase: "Interestingly,"

Phrase: "all four patients with 19p13 rearrangements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "males."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]
Processing 00000000.tx.127: The add(19)(p13) was the sole chromosome abnormality in one patient. 

Phrase: "The add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "the sole chromosome abnormality in one patient."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0008625:Chromosome Abnormality [Cell or Molecular Dysfunction]
   778   C0008626:CHROMOSOME ABNORMALITY [Disease or Syndrome]
   748   C0008633:Chromosome [Cell Component]
   748   C1704258:Abnormality [Finding]
Processing 00000000.tx.128: These patients all had monoclonal immunoglobulin of IgG/ isotype and showed extra-MM at diagnosis, compared with 15% and 27.5%, respectively, in those patients with non-add(19)(p13) CA in this study (P=0.037 and 0.01, respectively). 

Phrase: "These patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "all"

Phrase: "had"

Phrase: "monoclonal immunoglobulin of IgG/ isotype"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0443737:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C0700271:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   797   C0020852:Immunoglobulin IgG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   797   C0021017:Immunoglobulin isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   797   C0946139:IgG.monoclonal [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]
   760   C1621846:immunoglobulin [Molecular Function]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "extra-MM at diagnosis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   760   C0439064:Multiple [Quantitative Concept]
   760   C3538749:Myeloma [Intellectual Product]

Phrase: "compared with 15%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "27.5%,"

Phrase: "respectively,"

Phrase: "in those patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with non-add(19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1518422:Non [Functional Concept]
   827   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "CA in this study"

Phrase: "(P=0.037"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "0.01,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.129: Of the 88 patients who underwent FISH analysis, the differences of the bioclinical characteristics between the patients with the specific FISH_CA and those without were also compared. 

Phrase: "Of the 88 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "underwent"

Phrase: "FISH analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "the differences of the bioclinical characteristics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "between the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with the specific FISH_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "those without"

Phrase: "were"

Phrase: "also"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.130: Patients with FISH_13 had a higher incidence of extra-MM (P=0.02) at diagnosis. 

Phrase: "Patients with FISH_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a higher incidence of extra-MM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021149:Incidence [Quantitative Concept]
   748   C0220856:incidence [Functional Concept]

Phrase: "(P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "at diagnosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.131: Additionally, the incidence of trisomy 11 in patients was associated with IgG MM (P=0.042). 

Phrase: "Additionally,"

Phrase: "the incidence of trisomy 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "was"

Phrase: "associated with IgG MM"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   844   C2347303:Multiple Myeloma-IgG [Finding]
   806   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0563306:IgG myeloma [Neoplastic Process]
   760   C0439064:Multiple [Quantitative Concept]
   760   C3538749:Myeloma [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(P=0.042"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.132: Association between CG_CA and clinical outcome Notably, the patients with CG_CA had a significantly shorter median OS than the patients with normal karyotypes (184.2 versus 285.1 months; P=0.029) (Figure 2A). 

Phrase: "Association between CG_CA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "clinical outcome Notably,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1274040:Outcome [Functional Concept]

Phrase: "the patients with CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a significantly shorter median OS than the patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
   742   C0282416:Overall [Intellectual Product]
   742   C1561607:Overall [Qualitative Concept]

Phrase: "with normal karyotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0333684:Normal karyotype [Organism Attribute]
   983   C0863140:Normal karyotype [Finding]
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]

Phrase: "(184.2"

Phrase: "versus"

Phrase: "285.1 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "; P=0.029"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figure 2A"

Phrase: ")."
Processing 00000000.tx.133: In univariate analysis, other clinical and laboratory variables that were associated with shorter OS were stage III disease (P=0.009), BM plasmacytosis 30% (P=0.006), Hb <10 g/dl (P=0.006), PLA <1.5 x 1011/l (P <0.001), LDH 465 IU/l (P=0.032), Cr 2 mg/dl (P <0.001), CRP 4 mg/dl (P=0.006) and 2M 2.5 mg/l (P=0.012). 

Phrase: "In univariate analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683962:univariate analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "other clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "laboratory variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "associated with shorter OS"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C0282416:Overall [Intellectual Product]
   760   C1561607:Overall [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726   C1282927:short [Qualitative Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C1806781:Short [Quantitative Concept]
   726   C2350002:Short [Quantitative Concept]

Phrase: "were"

Phrase: "stage III disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0441771:Stage III [Intellectual Product]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205390:Stage [Temporal Concept]
   827   C0439070:III [Intellectual Product]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]
   827   C1705160:III [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(P=0.009"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "BM plasmacytosis 30%"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   923   C0238803:BONE MARROW PLASMACYTOSIS [Finding]
   861   C0005953:Bone Marrow [Tissue]
   812   C0085663:Plasmacytosis [Disease or Syndrome]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]

Phrase: "(P=0.006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Hb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "<10 g/dl (P=0.006"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439267:g/dL [Quantitative Concept]
           g%
   799   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "PLA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005821:Platelet [Cell]
   916 E C1963076:Platelets [Finding]

Phrase: "<1.5 x 1011/l (P <0.001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0450317:1011 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "LDH 465 IU/l (P=0.032"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   855   C0022917:LACTATE DEHYDROGENASE L [Amino Acid, Peptide, or Protein,Enzyme]
           Lactate Dehydrogenase
   812   C0439457:IU/L [Quantitative Concept]
   793   C0022924:lactate [Organic Chemical]
   793   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   793   C0439453:IU [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Cr 2 mg/dl (P <0.001"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0439269:mg dl [Quantitative Concept]
           mg%
   795   C0010294:Creatinine [Biologically Active Substance,Organic Chemical]
   795   C1561535:Creatinine [Finding]
   795   C1960952:mg % [Quantitative Concept]
   795   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "CRP 4 mg/dl (P=0.006"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0006560:C-reactive protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1879974:C-Reactive Protein [Gene or Genome]
   807   C0439269:mg dl [Quantitative Concept]
           mg%
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0205332:Reactive [Qualitative Concept]
   791   C1960952:mg % [Quantitative Concept]
   791   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   791   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "2M 2.5 mg/l (P=0.012"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   807   C0439268:mg/L [Quantitative Concept]
   791   C0439269:mg% [Quantitative Concept]
   791   C1960952:mg % [Quantitative Concept]
   791   C1979927:Microglobulin [Amino Acid, Peptide, or Protein]
   791   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.134: In multivariate analysis, only the CG_CA [relative risk (RR) of death 1.9; 95% confidence interval (CI) 1.23.2; P=0.009], PLA <1.5 x 1011/l (RR of death 2.1; 95% CI 1.33.4; P=0.001) and Cr 2 mg/dl (RR of death 2.5; 95% CI 1.54; P <0.001) were the independent prognostic factors for OS. 

Phrase: "In multivariate analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026777:Multivariate Analysis [Quantitative Concept]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "[relative risk (RR) of death 1.9"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0425043:Death of relative [Finding]
           relative death
   790   C0242492:Relative Risk [Quantitative Concept]
   783   C0966318:RISK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0035647:Risk [Qualitative Concept]
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "; 95% confidence interval (CI) 1.23.2"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   827   C0009667:Confidence Interval [Quantitative Concept]
   799   C0237529:Confidence [Mental Process]
   799   C0450348:23 [Quantitative Concept]
   799   C1272706:Interval [Temporal Concept]
   799   C1552654:Interval [Idea or Concept]
   799   C1552713:Interval [Intellectual Product]
   799   C1704725:Confidence [Qualitative Concept]
   799   C1704726:Confidence [Mental Process]
   727 E C0558095:Confident [Individual Behavior]

Phrase: "; P=0.009"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "],"

Phrase: "PLA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005821:Platelet [Cell]
   916 E C1963076:Platelets [Finding]

Phrase: "<1.5 x 1011/l (RR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0242492:Relative Risk [Quantitative Concept]
   795   C0035647:Risk [Qualitative Concept]
   795   C0080103:Relative [Family Group]
   795   C0205345:Relative [Qualitative Concept]
   795   C1547039:*Relative [Quantitative Concept]

Phrase: "of death 2.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011065:Death [Organism Function]
   827   C1306577:Death, NOS [Finding]

Phrase: "; 95% CI 1.33.4"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0009667:Confidence Interval [Quantitative Concept]
   799   C0237529:Confidence [Mental Process]
   799   C1272706:Interval [Temporal Concept]
   799   C1552654:Interval [Idea or Concept]
   799   C1552713:Interval [Intellectual Product]
   799   C1704725:Confidence [Qualitative Concept]
   799   C1704726:Confidence [Mental Process]
   727 E C0558095:Confident [Individual Behavior]

Phrase: "; P=0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "Cr 2 mg/dl (RR of death 2.5"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   775   C0425043:Death of relative [Finding]
           relative death
   760   C0242492:Relative Risk [Quantitative Concept]
   739   C0035647:Risk [Qualitative Concept]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "; 95% CI 1.54"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0009667:Confidence Interval [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C1272706:Interval [Temporal Concept]
   804   C1552654:Interval [Idea or Concept]
   804   C1552713:Interval [Intellectual Product]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: "; P <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "the independent prognostic factors for OS."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C1514474:Prognostic/Survival Factor [Clinical Attribute]
           Prognostic Factor
   748   C0220901:prognostic [Intellectual Product]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.135: CG_CA remained as an independent prognostic factor on OS only if the patients who had received chemotherapy were analyzed and the response to chemotherapy, as a bimodal covariate (responders versus non-responders), was also included in the multivariate analysis (data not shown). 

Phrase: "CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "remained as an independent prognostic factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1514474:Prognostic Factor [Clinical Attribute]
   753   C0085862:Independent [Idea or Concept]
   753   C0220901:prognostic [Intellectual Product]
   753   C1299583:Independent [Finding]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "on OS only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C0282416:Overall [Intellectual Product]
   827   C1561607:Overall [Qualitative Concept]

Phrase: "if"

Phrase: "the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "had"

Phrase: "received chemotherapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0013217:chemotherapy [Functional Concept]
   861   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "the response to chemotherapy,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "as"

Phrase: "a bimodal covariate"

Phrase: "(responders"

Phrase: "versus"

Phrase: "non-responders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "also"

Phrase: "included in the multivariate analysis"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0026777:Multivariate Analysis [Quantitative Concept]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332257:included [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.136: View larger version (26K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.137: KaplanMeier survival curves of the multiple myeloma (MM) patients showing (A) the overall survival in the patients with normal karyotypes is longer than those with chromosomal abnormalities (CA) detected by conventional cytogenetics (CG_CA); 

Phrase: "KaplanMeier survival curves of the multiple myeloma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   714   C0205134:Curve [Spatial Concept]

Phrase: "(MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ")"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(A)"

Phrase: "the overall survival in the patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
   753   C0282416:Overall [Intellectual Product]
   753   C1561607:Overall [Qualitative Concept]

Phrase: "with normal karyotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0333684:Normal karyotype [Organism Attribute]
   983   C0863140:Normal karyotype [Finding]
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]

Phrase: "is"

Phrase: "longer than those"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0205166:Long [Qualitative Concept]
   756   C1706317:Long [Qualitative Concept]
   706 E C1444754:Length [Quantitative Concept]
   706 E C1706316:LENGTH [Research Activity]

Phrase: "with chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
  1000   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "(CA)"

Phrase: "detected by conventional cytogenetics (CG_CA)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   770   C0439858:Conventional [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.138: (B) among the 44 patients with CG_CA, the overall survival in the hyperdiploid group is longer than in the non-hyperdiploid group; 

Phrase: "(B) among the 44 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347469:/B [Quantitative Concept]

Phrase: "with CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "the overall survival in the hyperdiploid group"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   748   C0282416:Overall [Intellectual Product]
   748   C1561607:Overall [Qualitative Concept]

Phrase: "is"

Phrase: "longer than"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0205166:Long [Qualitative Concept]
   799   C1706317:Long [Qualitative Concept]
   750 E C1444754:Length [Quantitative Concept]
   750 E C1706316:LENGTH [Research Activity]

Phrase: "in the non-hyperdiploid group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ";"
Processing 00000000.tx.139: (C) patients with CA other than CA_13 had better prognosis in comparison with patients with CA_13; 

Phrase: "(C) patients with CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "other than CA_13"

Phrase: "had"

Phrase: "better prognosis in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033325:Prognosis [Health Care Activity]

Phrase: "with patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CA_13"

Phrase: ";"
Processing 00000000.tx.140: (D) the patients with CA other than add(19)(p13) had better overall survival in comparison to patients with add(19)(p13); 

Phrase: "("

Phrase: "D)"

Phrase: "the patients with CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "other than add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "had"

Phrase: "better overall survival in comparison to patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   748   C0282416:Overall [Intellectual Product]
   748   C1561607:Overall [Qualitative Concept]

Phrase: "with add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.141: (E) in the subgroup analysis of 88 patients who had undertaken CG and FISH analyses simultaneously, the overall survival of patients without FISH_13 was longer than that of patients with FISH_13; 

Phrase: "(E) in the subgroup analysis of 88 patients"

Phrase: "who"

Phrase: "had"

Phrase: "undertaken CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "FISH analyses simultaneously,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   766   C0002778:Analysis [Laboratory Procedure]
   766   C0936012:Analysis [Research Activity]
   766   C1524024:analysis [Functional Concept]
   734   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]

Phrase: "the overall survival of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C0282416:Overall [Intellectual Product]
   760   C1561607:Overall [Qualitative Concept]

Phrase: "without FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "longer than that of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]

Phrase: "with FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.142: (F) significant differences in survival were noted between patients with CG_13, patients with FISH_13 only but without CG_13, and other patients without CG_13 or FISH_13.  

Phrase: "(F) significant differences in survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "noted between patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   824   C2360554:Patient Note [Clinical Attribute]
   790   C0030705:Patients [Patient or Disabled Group]
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]

Phrase: "with CG_13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "patients with FISH_13 only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "but without CG_13,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   770   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "other patients without CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "or"

Phrase: "FISH_13."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.143: Among the 44 patients with the CG_CA, the median OS for patients with hyperdiploidy, pseudodiploidy, hypodiploidy and tri-/tetraploidy was 2512.8, 188.1, 95.2 and 70 months, respectively (P=0.05). 

Phrase: "Among the 44 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with the CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "the median OS for patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
   753   C0282416:Overall [Intellectual Product]
   753   C1561607:Overall [Qualitative Concept]

Phrase: "with hyperdiploidy,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1305143:Hyperdiploidy [Cell or Molecular Dysfunction]
   944 E C0032578:Polyploidies [Cell or Molecular Dysfunction]

Phrase: "pseudodiploidy,"

Phrase: "hypodiploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333691:Hypodiploidy [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "tri-/tetraploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333694:Tetraploidy [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "2512.8,"

Phrase: "188.1,"

Phrase: "95.2"

Phrase: "and"

Phrase: "70 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "respectively"

Phrase: "(P=0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.144: Patients with hyperdiploid MM had a significantly longer median survival in comparison with non-hyperdiploid MM patients (2512.8 versus 124 months; P=0.025) (Figure 2B). 

Phrase: "Patients with hyperdiploid MM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a significantly longer median survival in comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]

Phrase: "with non-hyperdiploid MM patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   881   C1829939:{Non-patient} [Clinical Attribute]
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "(2512.8"

Phrase: "versus"

Phrase: "124 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "; P=0.025"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figure 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.145: Furthermore, among the patients with CG_CA, patients with CG_13 had a significantly shorter median survival in comparison with patients without this CA (93.5 versus 2213.5 months; P=0.047) (Figure 2C). 

Phrase: "Furthermore,"

Phrase: "among the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "patients with CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a significantly shorter median survival in comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]

Phrase: "with patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "without this CA (93.5"

Phrase: "versus"

Phrase: "2213.5 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "; P=0.047"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figure 2C"

Phrase: ")."
Processing 00000000.tx.146: In addition, the four patients with add(19)(p13) were found to have much shorter OS than the patients with other CA (2.52.5 versus 185.8 months; P=0.032) (Figure 2D). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the four patients with add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "much shorter OS than the patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   748   C0282416:Overall [Intellectual Product]
   748   C1561607:Overall [Qualitative Concept]

Phrase: "with other CA (2.52.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:CA+2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "versus"

Phrase: "185.8 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "; P=0.032"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figure"

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.147: No other recurrent CG_CA showed a significant impact on OS among patients with CG_CA. 

Phrase: "No"

Phrase: "other recurrent CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant impact on OS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "among patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_CA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
Processing 00000000.tx.148: To determine the most important factor contributing to shortened survival in patients with CG_CA, the ploidy status (hyperdiploidy versus non-hyperdiploidy), CG_13, add(19)(p13), as well as IgA isotype, PLA <1.5 x 1011/l and Cr 2 mg/dl that were associated with shorter OS by univariate analysis, were subsequently tested by multivariate analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the most important factor contributing to shortened survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contributing [Activity]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "the ploidy status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "(hyperdiploidy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1305143:Hyperdiploidy [Cell or Molecular Dysfunction]
   944 E C0032578:Polyploidies [Cell or Molecular Dysfunction]

Phrase: "versus"

Phrase: "non-hyperdiploidy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1305143:Hyperdiploidy [Cell or Molecular Dysfunction]
   861   C1518422:Non [Functional Concept]
   805 E C0032578:Polyploidies [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: ","

Phrase: "CG_13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "IgA isotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "PLA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005821:Platelet [Cell]
   916 E C1963076:Platelets [Finding]

Phrase: "<1.5 x 1011/l"

Phrase: "and"

Phrase: "Cr 2 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "associated with shorter OS"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C0282416:Overall [Intellectual Product]
   760   C1561607:Overall [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726   C1282927:short [Qualitative Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C1806781:Short [Quantitative Concept]
   726   C2350002:Short [Quantitative Concept]

Phrase: "by univariate analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683962:univariate analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "tested by multivariate analysis."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0026777:Multivariate Analysis [Quantitative Concept]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0392366:tested [Intellectual Product]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
Processing 00000000.tx.149: Our data showed that only add(19)(p13), Cr 2 mg/dl and PLA <1.5 x 1011/l were independent prognostic factors, and the associated RRs of death were 7.2 (95% CI 225.8), 3.4 (95% CI 1.38.7) and 2.9 (95% CI 1.36.5), respectively (P=0.002, 0.011 and 0.012, respectively). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that only add(19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]
   827   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "Cr 2 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "PLA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005821:Platelet [Cell]
   916 E C1963076:Platelets [Finding]

Phrase: "<1.5 x 1011/l"

Phrase: "were"

Phrase: "independent prognostic factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C1514474:Prognostic Factor [Clinical Attribute]
   827   C0220901:prognostic [Intellectual Product]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "the associated RRs of death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1849334:RRS [Disease or Syndrome]

Phrase: "were"

Phrase: "7.2"

Phrase: "(95% CI 225.8"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0009667:Confidence Interval [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C1272706:Interval [Temporal Concept]
   804   C1552654:Interval [Idea or Concept]
   804   C1552713:Interval [Intellectual Product]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442757:3 4 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(95% CI 1.38.7"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0009667:Confidence Interval [Quantitative Concept]
   799   C0237529:Confidence [Mental Process]
   799   C1272706:Interval [Temporal Concept]
   799   C1552654:Interval [Idea or Concept]
   799   C1552713:Interval [Intellectual Product]
   799   C1704725:Confidence [Qualitative Concept]
   799   C1704726:Confidence [Mental Process]
   727 E C0558095:Confident [Individual Behavior]

Phrase: ")"

Phrase: "and"

Phrase: "2.9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(95% CI 1.36.5"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0009667:Confidence Interval [Quantitative Concept]
   799   C0237529:Confidence [Mental Process]
   799   C1272706:Interval [Temporal Concept]
   799   C1552654:Interval [Idea or Concept]
   799   C1552713:Interval [Intellectual Product]
   799   C1704725:Confidence [Qualitative Concept]
   799   C1704726:Confidence [Mental Process]
   727 E C0558095:Confident [Individual Behavior]

Phrase: ")"

Phrase: ","

Phrase: "respectively"

Phrase: "(P=0.002,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "0.011"

Phrase: "and"

Phrase: "0.012,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450301:0.012" [Quantitative Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.150: Association between FISH_CA and clinical outcome Among the 88 patients who had undertaken the CG and FISH analysis simultaneously, patients with FISH_13 had a shorter OS in comparison with patients without this CA (132.2 versus 329 months; P=0.014) (Figure 2E). 

Phrase: "Association between FISH_CA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "clinical outcome Among the 88 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1547647:Patient Outcome [Idea or Concept]
   753   C1274040:Outcome [Functional Concept]

Phrase: "who"

Phrase: "had"

Phrase: "undertaken"

Phrase: "the CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "FISH analysis simultaneously,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0936012:Analysis [Research Activity]
   799   C1524024:analysis [Functional Concept]
   734   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]

Phrase: "patients with FISH_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a shorter OS in comparison"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
   753   C0282416:Overall [Intellectual Product]
   753   C1561607:Overall [Qualitative Concept]

Phrase: "with patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "without this CA (132.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0596235:CA+2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "versus"

Phrase: "329 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "; P=0.014"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450302:0.014" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figure 2E"

Phrase: ")."
Processing 00000000.tx.151: FISH_13, BM plasmacytosis 30%, LDH 465 IU/l, Cr 2 mg/dl, CRP 4 mg/dl and response to chemotherapy chosen from univariate analysis were tested in subsequent multivariate analysis. 

Phrase: "FISH_13,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "BM plasmacytosis 30%,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   923   C0238803:BONE MARROW PLASMACYTOSIS [Finding]
   861   C0005953:Bone Marrow [Tissue]
   812   C0085663:Plasmacytosis [Disease or Syndrome]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1546708:Marrow [Intellectual Product]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]

Phrase: "LDH 465 IU/l,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C0022917:LACTATE DEHYDROGENASE L [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0439457:IU/L [Quantitative Concept]

Phrase: "Cr 2 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "CRP 4 mg/dl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "response to chemotherapy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "chosen from univariate analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0683962:univariate analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1707391:Chosen [Activity]

Phrase: "were"

Phrase: "tested in subsequent multivariate analysis."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0026777:Multivariate Analysis [Quantitative Concept]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332282:Subsequent [Temporal Concept]
   760   C0392366:tested [Intellectual Product]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
Processing 00000000.tx.152: The CA of FISH_13 was the best independent predictor of a shorter OS (RR of death 3.7; 95% CI 27; P <0.001). 

Phrase: "The CA of FISH_13"

Phrase: "was"

Phrase: "the best independent predictor of a shorter OS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2698872:Predictor [Idea or Concept]

Phrase: "(RR of death 3.7"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0425043:Death of relative [Finding]
           relative death
   790   C0242492:Relative Risk [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "; 95% CI 27"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: "; P <0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.153: Another prognostic factor that remained significant in the multivariate analysis was Cr 2 mg/dl (RR of death 2.6; 95% CI 1.44.9; P=0.004). 

Phrase: "Another prognostic factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1514474:Prognostic Factor [Clinical Attribute]
   861   C0220901:prognostic [Intellectual Product]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that remained significant in the multivariate analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237881:significant [Quantitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "Cr 2 mg/dl (RR of death 2.6"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   775   C0425043:Death of relative [Finding]
           relative death
   760   C0242492:Relative Risk [Quantitative Concept]
   739   C0035647:Risk [Qualitative Concept]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "; 95% CI 1.44.9"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0009667:Confidence Interval [Quantitative Concept]
   799   C0237529:Confidence [Mental Process]
   799   C1272706:Interval [Temporal Concept]
   799   C1552654:Interval [Idea or Concept]
   799   C1552713:Interval [Intellectual Product]
   799   C1704725:Confidence [Qualitative Concept]
   799   C1704726:Confidence [Mental Process]
   727 E C0558095:Confident [Individual Behavior]

Phrase: "; P=0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.154: Interestingly, significant differences in OS could also be demonstrated among the three groups of patients with CG_13, FISH_13 only without CG_13, and other karyotypes with neither CG_13 nor FISH_13 (97.8, 152.8 and 328.9 months, respectively; P=0.013) (Figure 2F).  

Phrase: "Interestingly,"

Phrase: "significant differences in OS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "demonstrated among the three groups of patients"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0205449:Three [Quantitative Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552839:groups [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "with CG_13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "FISH_13 only without CG_13,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
           fluorescence hybridization situ
   790   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   764   C0444498:In situ [Spatial Concept]
   742   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0020202:Hybridisation [Genetic Function]
   742   C0205171:Only [Quantitative Concept]
   742   C1300517:Hybridization [Laboratory Procedure]
   742   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "other karyotypes with neither CG_13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022526:karyotypes [Laboratory Procedure]
   753   C0178725:karyotypes [Laboratory or Test Result]
   753   C1261273:Karyotypes [Organism Attribute]

Phrase: "nor"

Phrase: "FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(97.8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "152.8"

Phrase: "and"

Phrase: "328.9 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "respectively"

Phrase: "; P=0.013"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figure 2F"

Phrase: ")."
Processing 00000000.tx.155: Discussion Top Abstract Introduction Patients and methods Results Discussion References  The prevalence of CG_CA was 29.3% in the cohort of 150 Chinese patients with newly diagnosed MM. 

Phrase: "Discussion Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The prevalence of CG_CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "was"

Phrase: "29.3% in the cohort of 150 Chinese patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0008120:chinese [Language]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0152035:Chinese [Population Group]
   742   C0599755:Cohort [Population Group]

Phrase: "with newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.156: The majority of CG_CA cases showed complex structural and numerical changes, and involved hyperdiploid chromosomes. 

Phrase: "The majority of CG_CA cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "complex structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "numerical changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "involved hyperdiploid chromosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]
Processing 00000000.tx.157: In general, the incidence of CG_CA and the frequent non-random abnormalities in our study were comparable to those from Western countries [2, 5, 6, 1012, 20, 22]. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "the incidence of CG_CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "and"

Phrase: "the frequent non-random abnormalities in our study"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0000768:Abnormalities [Congenital Abnormality]
   744   C0000769:abnormalities [Functional Concept]
   711 E C1704258:Abnormality [Finding]

Phrase: "were"

Phrase: "comparable to those from Western countries"

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "1012,"

Phrase: "20,"

Phrase: "22"

Phrase: "]."
Processing 00000000.tx.158: In line with the findings that patients with CG_CA had a larger tumor burden, a higher labeling index and Ki-67 growth fraction of PC when compared with the patients without CG_CA [6, 7, 35, 36], we found that the prevalence of CG_CA was higher in stage III than in stage I disease, and the patients with CG_CA had significantly higher BM plasmacytosis, lower levels of platelets and higher incidence of extra-MM than the patients with normal karyotypes. 

Phrase: "In line with the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "that patients with CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a larger tumor burden,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1449699:Tumor Burden [Diagnostic Procedure]
   827   C2828008:Burden [Idea or Concept]
   717   C0475278:Large tumor [Qualitative Concept]

Phrase: "a higher labeling index"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0812425:Labeling Index [Laboratory or Test Result]
   901   C2698830:Labeling Index [Laboratory Procedure]
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "and"

Phrase: "Ki-67 growth fraction of PC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   774   C0805525:Cell Fraction [Cell Component]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "when"

Phrase: "compared with the patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1707455:Compared [Activity]

Phrase: "without CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "[6,"

Phrase: "7,"

Phrase: "35,"

Phrase: "36"

Phrase: "],"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the prevalence of CG_CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "was"

Phrase: "higher in stage III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in stage I disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C0441766:Stage I [Intellectual Product]

Phrase: "and"

Phrase: "the patients with CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "significantly higher BM plasmacytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0238803:BONE MARROW PLASMACYTOSIS [Finding]
   804   C0085663:Plasmacytosis [Disease or Syndrome]

Phrase: "lower levels of platelets"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "higher incidence of extra-MM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "than the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with normal karyotypes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0333684:Normal karyotype [Organism Attribute]
   983   C0863140:Normal karyotype [Finding]
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]
Processing 00000000.tx.159: We demonstrated that the CG_CA in MM was associated with a shorter OS. 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the CG_CA in MM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "associated with a shorter OS."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
   753   C0282416:Overall [Intellectual Product]
   753   C1561607:Overall [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719   C1282927:short [Qualitative Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
   719   C1806781:Short [Quantitative Concept]
   719   C2350002:Short [Quantitative Concept]
Processing 00000000.tx.160: Although CG_CA was associated with a high proliferative index of PC and advanced tumor stage, it was still an independent prognostic factor on multivariate analysis. 

Phrase: "Although"

Phrase: "CG_CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "associated with a high proliferative index of PC"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   764   C0032112:Plasma cell [Cell]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1514489:Proliferative Index [Quantitative Concept]
   762   C0699040:cell associated [Cell Component]
   742   C0007634:Cell [Cell]
   742   C0032105:Plasma [Body Substance]
   742   C0205250:High [Qualitative Concept]
   742   C0334094:Proliferative [Pathologic Function]
   742   C0918012:Index [Intellectual Product]
   742   C1269647:Cell [Cell]
   742   C1299351:High [Qualitative Concept]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1552854:index [Idea or Concept]
   742   C1637833:% index [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2700149:HIGH [Intellectual Product]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "advanced tumor stage,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1300072:Tumor stage [Clinical Attribute]
           Stage
   827   C0027651:Tumor [Neoplastic Process]
   827   C0205390:Stage [Temporal Concept]
   827   C1306673:Stage [Qualitative Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]

Phrase: "it"

Phrase: "was"

Phrase: "still"

Phrase: "an independent prognostic factor on multivariate analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1514474:Prognostic Factor [Clinical Attribute]
   774   C0085801:Analysis, Factor [Quantitative Concept]
   748   C0220901:prognostic [Intellectual Product]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.161: In addition, there were distinct differences in clinical and laboratory features between hyperdiploid and non-hyperdiploid MM. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "were"

Phrase: "distinct differences in clinical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "features between hyperdiploid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1521970:Feature [Qualitative Concept]
   790   C1706388:Feature [Conceptual Entity]
   790   C2346469:Feature [Qualitative Concept]
   790   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "non-hyperdiploid MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   812   C0439064:Multiple [Quantitative Concept]
   812   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.162: The former was more frequently associated with CG_CA of multiple trisomies, whereas the latter was more associated with the CG_13 and CG_14q32. 

Phrase: "The former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "was"

Phrase: "more frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332183:Frequently [Temporal Concept]

Phrase: "associated with CG_CA of multiple trisomies,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   748   C0041107:Trisomies [Disease or Syndrome]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0439858:Conventional [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "whereas"

Phrase: "the latter"

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "associated with the CG_13"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "CG_14q32."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520599:14q32 [Cell Component]
Processing 00000000.tx.163: Importantly, the median OS was significantly shorter in the patients with non-hyperdiploid MM than in those with hyperdiploid MM (12 versus 25 months), especially in those with hypodiploid (9 months) and tri-/tetraploid chromosomes (7 months), which were considered as the same diploidy status [12]. 

Phrase: "Importantly,"

Phrase: "the median OS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C0282416:Overall [Intellectual Product]
   827   C1561607:Overall [Qualitative Concept]

Phrase: "was"

Phrase: "significantly shorter in the patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1282927:short [Qualitative Concept]
   726   C1806781:Short [Quantitative Concept]
   726   C2350002:Short [Quantitative Concept]

Phrase: "with non-hyperdiploid MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   812   C0439064:Multiple [Quantitative Concept]
   812   C3538749:Myeloma [Intellectual Product]

Phrase: "than"

Phrase: "in those with hyperdiploid MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   812   C0439064:Multiple [Quantitative Concept]
   812   C3538749:Myeloma [Intellectual Product]

Phrase: "(12"

Phrase: "versus"

Phrase: "25 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "especially in those with hypodiploid"

Phrase: "(9 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "tri-/tetraploid chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]

Phrase: "(7 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "were"

Phrase: "considered as the same diploidy status"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1278655:SAME AS [Classification]
   753   C0012568:Diploidy [Organism Attribute]
   753   C0445247:Same [Qualitative Concept]
   753   C0449438:Status [Qualitative Concept]
   753   C0750591:considered [Idea or Concept]

Phrase: "[12"

Phrase: "]."
Processing 00000000.tx.164: Neither CG_13 nor CG_14q32 could be used to further separate non-hyperdiploidy MM into different prognostic categories. 

Phrase: "Neither CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "nor"

Phrase: "CG_14q32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520599:14q32 [Cell Component]

Phrase: "could"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "non-hyperdiploidy MM into different prognostic categories."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   744   C0439064:Multiple [Quantitative Concept]
   744   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.165: These findings are similar to reports from Western countries [1012], and suggest that the two distinct groups of MM, delineated by the chromosome ploidy and patterns of CG_CA, truly exist without ethnic or geographical variations. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "similar to reports"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "from Western countries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454664:Countries [Geographic Area]

Phrase: "[1012"

Phrase: "],"

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the two distinct groups of MM,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552839:groups [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "delineated by the chromosome ploidy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0008633:Chromosome [Cell Component]
   760   C0032246:Ploidy [Quantitative Concept]

Phrase: "and"

Phrase: "patterns of CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "truly"

Phrase: "exist without ethnic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015031:ETHNIC [Population Group]
   790   C0680174:ethnic [Finding]
   790   C2987476:Exist [Conceptual Entity]

Phrase: "or"

Phrase: "geographical variations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variations [Qualitative Concept]
Processing 00000000.tx.166: However, the pathogenesis and mechanism for the survival differences between the two groups are still obscure. 

Phrase: "However,"

Phrase: "the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "and"

Phrase: "mechanism for the survival differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "between the two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "are"

Phrase: "still"

Phrase: "obscure."
Processing 00000000.tx.167: Unfortunately, further studies are partly hampered by lack of suitable cell lines derived from the hyperdiploid MM [11]. 

Phrase: "Unfortunately,"

Phrase: "further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "partly"

Phrase: "hampered by lack of suitable cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0007600:Cell lines [Cell]
   748   C0007634:Cell [Cell]
   748   C0205132:lines [Spatial Concept]
   748   C0332268:lack [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "derived from the hyperdiploid MM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   753   C0439064:Multiple [Quantitative Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]
   753   C3538749:Myeloma [Intellectual Product]

Phrase: "[11"

Phrase: "]."
Processing 00000000.tx.168: We recently developed a new SCID mouse/human chimeric animal model, which can sustain the viability and growth of primary MM cells and might be beneficial in facilitating further studies [37]. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "developed"

Phrase: "a new SCID mouse/human chimeric animal model,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C2986594:Mouse Model [Experimental Model of Disease]
   818   C0599779:Animal Model [Animal]
   795   C0003062:Animal [Animal]
   795   C3161035:Model [Intellectual Product]

Phrase: "which"

Phrase: "can"

Phrase: "sustain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443318:sustain [Functional Concept]
  1000   C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "the viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "and"

Phrase: "growth of primary MM cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   809   C0007595:growth of cell [Cell Function]
           cells growth
   783   C3548680:primary growth [Organism Function]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "might"

Phrase: "be"

Phrase: "beneficial in facilitating further studies"

Phrase: "[37"

Phrase: "]."
Processing 00000000.tx.169: Owing to the low proliferative index of PC, CG used alone underestimates the prevalence of CA in MM [2, 11]. 

Phrase: "Owing to the low proliferative index"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1514489:Proliferative Index [Quantitative Concept]
   827   C0334094:Proliferative [Pathologic Function]
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "of PC,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032112:Plasma cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1269647:Cell [Cell]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "underestimates"

Phrase: "the prevalence of CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "11"

Phrase: "]."
Processing 00000000.tx.170: FISH enables identification of CA without requiring metaphases within the PC. 

Phrase: "FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "enables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "identification of CA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "without requiring metaphases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1621812:Metaphases [Cell Function]
   827 E C0025564:Metaphase [Cell Function]

Phrase: "within the PC."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032112:Plasma cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1269647:Cell [Cell]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.171: However, FISH can only provide information for specific target regions, which is of limited value in the interpretation of highly complex karyotypes in MM. 

Phrase: "However,"

Phrase: "FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "information for specific target regions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "which"

Phrase: "is of limited value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439801:Limited [Functional Concept]
   770   C1522609:Value [Quantitative Concept]
   770   C3542948:Limited [Intellectual Product]

Phrase: "in the interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "of highly complex karyotypes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C3273253:Complex Karyotype [Cell or Molecular Dysfunction]
   827   C0022526:karyotypes [Laboratory Procedure]
   827   C0178725:karyotypes [Laboratory or Test Result]
   827   C0439855:Complex [Qualitative Concept]
   827   C1261273:Karyotypes [Organism Attribute]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.172: In contrast, CG gives a complete overview of CA present in the malignant clone. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a complete overview of CA present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814812:overview [Intellectual Product]

Phrase: "in the malignant clone."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.173: Therefore, combining the two methods is particularly useful in the analysis of clinically relevant CA in MM. 

Phrase: "Therefore,"

Phrase: "combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "the two methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "particularly useful in the analysis of clinically relevant CA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1524063:Use of [Functional Concept]

Phrase: "in MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.174: In this study, patients with FISH_13 had a shorter median survival than those without this CA, and FISH_13 remained the best independent prognostic factor on the multivariate analysis. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "patients with FISH_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "a shorter median survival than those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]

Phrase: "without this CA,"

Phrase: "and"

Phrase: "FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "remained"

Phrase: "the best independent prognostic factor on the multivariate analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1514474:Prognostic Factor [Clinical Attribute]
   762   C0085801:Analysis, Factor [Quantitative Concept]
   742   C0220901:prognostic [Intellectual Product]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.175: Furthermore, there was a significant difference in the OS among patients with CG_13, patients with FISH_13 but without CG_13, and patients with neither CG_13 nor FISH_13 (median 9 versus 15 versus 32 months, respectively; P=0.013). 

Phrase: "Furthermore,"

Phrase: "there"

Phrase: "was"

Phrase: "a significant difference in the OS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "among patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "patients with FISH_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "but without CG_13,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   770   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "patients with neither CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "nor"

Phrase: "FISH_13"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(median 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0549183:Median [Spatial Concept]
   861   C0876920:Median [Quantitative Concept]
   861   C2347635:Median [Quantitative Concept]
   861   C2348144:Median [Quantitative Concept]
   861   C2939193:Median [Spatial Concept]

Phrase: "versus"

Phrase: "15"

Phrase: "versus"

Phrase: "32 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "respectively"

Phrase: "; P=0.013"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.176: It is likely that the net effect of 13 on prognosis is greater when 13 is detected by CG than when it is detected by FISH [21, 36]. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the net effect of 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on prognosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]

Phrase: "is"

Phrase: "greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "when"

Phrase: "13"

Phrase: "is"

Phrase: "detected by CG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "than"

Phrase: "when"

Phrase: "it"

Phrase: "is"

Phrase: "detected by FISH"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
           fluorescence hybridization situ
   833   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   790   C0444498:In situ [Spatial Concept]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0020202:Hybridisation [Genetic Function]
   753   C0442726:Detected [Finding]
   753   C1300517:Hybridization [Laboratory Procedure]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "[21,"

Phrase: "36"

Phrase: "]."
Processing 00000000.tx.177: This is because of the additive effects of a large tumor burden and a high proliferation rate of tumor cells, which usually accompany CG_CA, on the prognosis [11]. 

Phrase: "This"

Phrase: "is because of the additive effects of a large tumor burden"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C0475278:Large tumor [Qualitative Concept]
   756   C1449699:Tumor Burden [Diagnostic Procedure]
   738   C0027651:Tumor [Neoplastic Process]
   738   C0442796:Additive [Qualitative Concept]
   738   C0549177:Large [Quantitative Concept]
   738   C1280500:effects [Qualitative Concept]
   738   C1550602:Additive [Substance]
   738   C1578706:Tumor [Intellectual Product]
   738   C2828008:Burden [Idea or Concept]
   738   C3273930:Tumor [Finding]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "a high proliferation rate of tumor cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "which usually"

Phrase: "accompany"

Phrase: "CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "on the prognosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]

Phrase: "[11"

Phrase: "]."
Processing 00000000.tx.178: To the best of our knowledge, this is the first report to show that MM with add(19)(p13) is a distinct cytogenetic entity that is associated with the male gender, IgG/ isotype, presence of extra-MM and a poor prognosis. 

Phrase: "To the best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]

Phrase: "of our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MM with add(19"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   753   C0439064:Multiple [Quantitative Concept]
   753   C3538749:Myeloma [Intellectual Product]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "a distinct cytogenetic entity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551338:Entity [Entity]

Phrase: "that"

Phrase: "is"

Phrase: "associated with the male gender,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0024554:Male gender [Finding]
           Male
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1706180:Male Gender [Qualitative Concept]
           Male
   760   C0079399:Gender [Organism Attribute]
   760   C0086582:male [Population Group]
   760   C0804628:Gender [Clinical Attribute]
   760   C1522384:Gender [Organism Attribute]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "IgG/ isotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "presence of extra-MM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a poor prognosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0278252:Poor prognosis [Finding]
   861   C0033325:Prognosis [Health Care Activity]
Processing 00000000.tx.179: To further support the notion, two other previously treated MM patients, not included in this study, who had complex chromosome changes with add(19)(p13) at the time of referral from other hospitals were also male, had IgG/ isotype and showed extra-MM at that time (personal communication). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion,"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other previously"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "MM patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0026764:Multiple Myeloma [Neoplastic Process]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included in this study,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "who"

Phrase: "had"

Phrase: "complex chromosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosome [Cell Component]

Phrase: "changes with add(19"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   770   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of referral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034927:Referral [Health Care Activity]

Phrase: "from other hospitals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0019994:Hospitals [Health Care Related Organization,Manufactured Object]
  1000   C1609061:Hospitals [Intellectual Product]
   966 E C1510665:Hospital [Qualitative Concept]

Phrase: "were"

Phrase: "also male,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "had"

Phrase: "IgG/ isotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "extra-MM at"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   770   C0439064:Multiple [Quantitative Concept]
   770   C3538749:Myeloma [Intellectual Product]

Phrase: "that time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(personal communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: ")."
Processing 00000000.tx.180: From a review of available literature, non-random chromosomal rearrangements of 19p13 have been reported in four of 21 MM patients (19%) from Japan [38]. 

Phrase: "From a review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "of available literature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023866:Literature [Intellectual Product]
   861   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "non-random chromosomal rearrangements of 19p13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1515001:Chromosomal Rearrangement [Cell or Molecular Dysfunction]
   753   C1511695:Rearrangements [Genetic Function]

Phrase: "have"

Phrase: "been"

Phrase: "reported in four of 21 MM patients"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   750   C0747307:patients report [Intellectual Product]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0205450:Four [Quantitative Concept]
   744   C0439064:Multiple [Quantitative Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C3496591:Reported [Clinical Attribute]
   744   C3538749:Myeloma [Intellectual Product]
   711 E C3273238:Report [Intellectual Product]

Phrase: "(19%"

Phrase: ")"

Phrase: "from Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "[38"

Phrase: "]."
Processing 00000000.tx.181: One of these patients had add(19)(p13) and the other three had translocations involving 19p13. 

Phrase: "One of these patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "had"

Phrase: "add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "the other three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "had"

Phrase: "translocations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040715:Translocations [Cell or Molecular Dysfunction]
   966 E C2987521:Translocation [Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "19p13."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520840:19p13 [Cell Component]
Processing 00000000.tx.182: Additionally, all four patients had comparable clinical features to our patients, all were males with extra-MM and two of them had IgG/ isotypes [38]. 

Phrase: "Additionally,"

Phrase: "all four patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "comparable clinical features to our patients,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "all"

Phrase: "were"

Phrase: "males with extra-MM"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0024554:Males [Finding]
   760   C0086582:Males [Population Group]
   726 E C1706180:Male [Qualitative Concept]
   726 E C1706428:Male [Qualitative Concept]
   726 E C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "two of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "had"

Phrase: "IgG/ isotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "[38"

Phrase: "]."
Processing 00000000.tx.183: Notably, among the patients with CG_CA, the patients with add(19)(p13) were likely to have much shorter OS than the patients without this CA. 

Phrase: "Notably,"

Phrase: "among the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_CA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "the patients with add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "much shorter OS than the patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   748   C0282416:Overall [Intellectual Product]
   748   C1561607:Overall [Qualitative Concept]

Phrase: "without this CA."
Processing 00000000.tx.184: Rather than the CG_13 and non-hyperdiploidy, the presence of add(19)(p13) became the most powerful prognostic factor associated with short OS on multivariate analysis in the patients with CG_CA. 

Phrase: "Rather than"

Phrase: "the CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "non-hyperdiploidy,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1305143:Hyperdiploidy [Cell or Molecular Dysfunction]
   861   C1518422:Non [Functional Concept]
   805 E C0032578:Polyploidies [Cell or Molecular Dysfunction]

Phrase: "the presence of add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "became"

Phrase: "the most powerful prognostic factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1514474:Prognostic Factor [Clinical Attribute]
   812   C0220901:prognostic [Intellectual Product]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "associated with short OS"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
   760   C0282416:Overall [Intellectual Product]
   760   C1282927:short [Qualitative Concept]
   760   C1561607:Overall [Qualitative Concept]
   760   C1806781:Short [Quantitative Concept]
   760   C2350002:Short [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "on multivariate analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026777:Multivariate Analysis [Quantitative Concept]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "in the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with CG_CA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
Processing 00000000.tx.185: However, the prognostic impact of add(19)(p13) in MM needs to be confirmed by further studies involving a larger number of patients. 

Phrase: "However,"

Phrase: "the prognostic impact of add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "in MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "confirmed by further studies"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1517331:Further [Spatial Concept]
   737 E C0205108:far [Spatial Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C2603343:Study [Research Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "a larger number of patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C2360800:Number of patients [Finding]
   781   C1830427:Patient number [Intellectual Product]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.186: The genetic changes associated with the chromosomal abnormalities remain to be elucidated. 

Phrase: "The genetic changes"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
   966   C1705285:Genetic Change [Cell or Molecular Dysfunction]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "associated with the chromosomal abnormalities"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   806   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   760   C0008633:Chromosomal [Cell Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1704258:Abnormality [Finding]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.187: Several known genes mapped to the band 19p13.3, such as the E2A gene, which encodes the enhancer-binding protein E12/E47 and is rearranged in most cases of acute lymphoblastic leukemia with translocation t(1;19)(q23;p13.3) [39], and the basigin gene, which is a member of the Ig superfamily and plays a role in intercellular recognition [40], are potential candidates. 

Phrase: "Several known genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "mapped to the band 19p13.3,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1520850:19p13.3 [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1520840:19p13 [Cell Component]
   753   C1521913:band [Cell Component]
   719   C0024779:Map [Manufactured Object]
   719   C1706473:Map [Conceptual Entity]

Phrase: "such as the E2A gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "the enhancer-binding protein E12/E47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1336596:E47 [Gene or Genome]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "is"

Phrase: "rearranged in most cases of acute lymphoblastic leukemia"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   800   C0023449:Acute lymphoblastic leukaemia [Neoplastic Process]
           Lymphoblastic leukaemia
   800   C1961102:Lymphoblastic Leukemia, Acute [Neoplastic Process]
           Lymphoblastic Leukemia
   800   C3542401:Acute Lymphoblastic Leukemia [Intellectual Product]
   770   C0023448:Lymphoblastic leukemia [Neoplastic Process]
   767   C0085669:Acute leukaemia [Neoplastic Process]
   767   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205178:acute [Temporal Concept]
   744   C0229613:lymphoblastic [Cell]
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "with translocation t(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]

Phrase: ";19"

Phrase: ")"

Phrase: "(q23"

Phrase: ";p13.3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1334535:p13 [Gene or Genome]
   861   C1424876:p13 [Gene or Genome]
   861   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "[39"

Phrase: "],"

Phrase: "and"

Phrase: "the basigin gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "a member of the Ig superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in intercellular recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "[40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "],"

Phrase: "are"

Phrase: "potential candidates."
Processing 00000000.tx.188: Recently, a novel cryptic translocation involving 19p13.3 and IgH was found in chronic B-cell lymphocytic leukemia and large B-cell lymphoma [41], which hinted at the involvement of other novel genes. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a novel cryptic translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "19p13.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1520850:19p13.3 [Cell Component]
   861   C1520840:19p13 [Cell Component]

Phrase: "and"

Phrase: "IgH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017351:IGH [Gene or Genome]

Phrase: "was"

Phrase: "found in chronic B-cell lymphocytic leukemia"
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   897   C0023434:Chronic B-Cell Lymphocytic Leukemia [Neoplastic Process]
           B Cell Lymphocytic Leukemia
           Leukemia, B-Cell, Chronic
           B-Lymphocytic Leukemia, Chronic
           B-Cell Leukemia
           Chronic Lymphocytic Leukemia
   861 E C1868683:LEUKEMIA, CHRONIC LYMPHOCYTIC, B-CELL [Neoplastic Process]
   853   C2004493:Lymphocytic Leukemia, B-Cell [Neoplastic Process]
           Leukemia, B-Cell
   778   C0004561:B-cell [Cell]
   778   C0023448:Lymphocytic Leukemia [Neoplastic Process]
   774   C0024264:Lymphocytic cell [Cell]
           Lymphocytic
   774   C1279296:Chronic leukaemia [Neoplastic Process]
   748   C0007634:Cell [Cell]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C0150312:Found [Quantitative Concept]
   748   C0205191:chronic [Temporal Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2939172:Lymphocytic [Qualitative Concept]
   738   C1517806:Leukemic Cell [Cell]
   714 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "large B-cell lymphoma"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0024302:Large cell lymphoma [Neoplastic Process]
   923   C0079731:Lymphoma, B-Cell [Neoplastic Process]
   923   C0079744:Lymphoma, Large-Cell [Neoplastic Process]
   861   C0004561:B-cell [Cell]
   861   C0883208:cell lymphoma [Cell]
   812   C0007634:Cell [Cell]
   812   C0024299:Lymphoma [Neoplastic Process]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "[41"

Phrase: "],"

Phrase: "which"

Phrase: "hinted at the involvement of other novel genes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0017337:Genes [Gene or Genome]
   744   C0205314:Novel [Temporal Concept]
   744   C0679622:novel [Intellectual Product]
   744   C1314939:Involvement [Functional Concept]
   711   C1415545:HINT [Gene or Genome]
Processing 00000000.tx.189: In summary, CG and FISH analyses identified several chromosomal abnormalities highly associated with the clinical features and prognosis of newly diagnosed MM patients. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "FISH analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "several chromosomal abnormalities highly"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   861   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   812   C0000768:Abnormalities [Congenital Abnormality]
   812   C0000769:abnormalities [Functional Concept]
   779 E C1704258:Abnormality [Finding]
   729 E C0205161:Abnormal [Qualitative Concept]
   729 E C2347472:% Abnormal [Quantitative Concept]
   729 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "associated with the clinical features"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205210:Clinical [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726   C1521970:Feature [Qualitative Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "prognosis of newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033325:Prognosis [Health Care Activity]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "MM patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0026764:Multiple Myeloma [Neoplastic Process]
Processing 00000000.tx.190: Combined CG and FISH studies separated MM patients into three groups with significantly different OS; 

Phrase: "Combined CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "FISH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "separated MM patients into three groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "with significantly different OS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0038952:Survival [Activity]
   812   C0220921:survival [Functional Concept]
   812   C0282416:Overall [Intellectual Product]
   812   C1561607:Overall [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.191: one with CG_13, one with FISH_13 but not CG_13, and the remaining one with neither CG_13 nor FISH_13. 

Phrase: "one with CG_13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "one with FISH_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "but"

Phrase: "not CG_13,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010802:Cytogenetics [Biomedical Occupation or Discipline]
   827   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "the remaining one with neither CG_13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "nor"

Phrase: "FISH_13."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.192: The presence of add(19)(p13) as the sole chromosomal abnormality in one patient suggested that this CA plays a role in pathogenesis for a subset of MM patients and demonstrated the existence of a specific cytogenetic entity.  

Phrase: "The presence of add(19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ")"

Phrase: "as the sole chromosomal abnormality"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0008625:Chromosomal Abnormality [Cell or Molecular Dysfunction]
   901   C0008626:Chromosomal Abnormality [Disease or Syndrome]
   827   C1704258:Abnormality [Finding]
   755 E C0205161:Abnormal [Qualitative Concept]
   755 E C2347472:% Abnormal [Quantitative Concept]
   755 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "in one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this CA"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "for a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of MM patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0026764:Multiple Myeloma [Neoplastic Process]

Phrase: "and"

Phrase: "demonstrated"

Phrase: "the existence of a specific cytogenetic entity."
Processing 00000000.tx.193: Acknowledgements  This study was supported in part by grants NSC90-2314-B-002-268 and NSC91-2314-B-002-131 from the National Science Council of the Republic of China. 

Phrase: "Acknowledgements"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grants NSC90-2314-B-002-268"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0018173:Grants [Quantitative Concept]
   766 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "NSC91-2314-B-002-131 from the National Science Council"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0036397:Science [Occupation or Discipline]
   739   C1551807:Council [Population Group]
   739   C3245503:national [Intellectual Product]

Phrase: "of the Republic of China."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039260:Republic of China [Geographic Area]
   827   C0008115:China [Geographic Area]
Processing 00000000.tx.194: Received for publication April 3, 2005. 

Phrase: "Received for publication April 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2005."
Processing 00000000.tx.195: Accepted for publication April 20, 2005.  

Phrase: "Accepted for publication April 20,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2005."
Processing 00000000.tx.196: References Top Abstract Introduction Patients and methods Results Discussion References  1. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.197: Bergsagel PL, Kuehl WM. 

Phrase: "Bergsagel PL,"

Phrase: "Kuehl WM."
Processing 00000000.tx.198: Chromosome translocations in multiple myeloma. 

Phrase: "Chromosome translocations in multiple myeloma."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0040715:chromosome translocations [Cell or Molecular Dysfunction]
           Translocations
   726 E C2987521:Translocation [Activity]
Processing 00000000.tx.199: Oncogene 2001; 

Phrase: "Oncogene 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.200: 20: 56115622.[CrossRef][ISI][Medline] 2. 

Phrase: "20"

Phrase: ":"

Phrase: "56115622."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.201: Zandecki M, Lai JL, Facon T. 

Phrase: "Zandecki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lai JL,"

Phrase: "Facon T."
Processing 00000000.tx.202: Multiple myeloma: almost all patients are cytogenetically abnormal. 

Phrase: "Multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ":"

Phrase: "almost"

Phrase: "all patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "cytogenetically abnormal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205161:Abnormal [Qualitative Concept]
   861   C2347472:% Abnormal [Quantitative Concept]
   861   C2699333:ABNORMAL [Intellectual Product]
Processing 00000000.tx.203: Br J Haematol 1996; 

Phrase: "Br J Haematol 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.204: 94: 217227.[CrossRef][ISI][Medline] 3. 

Phrase: "94"

Phrase: ":"

Phrase: "217227."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.205: Cigudosa JC, Rao PH, Calasanz MJ et al. 

Phrase: "Cigudosa JC,"

Phrase: "Rao PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Calasanz MJ et al."
Processing 00000000.tx.206: Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. 

Phrase: "Characterization of nonrandom chromosomal gains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "losses in multiple myeloma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1517945:Loss [Quantitative Concept]

Phrase: "by comparative genomic hybridization."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0796358:Comparative Genomic Hybridization [Molecular Biology Research Technique]
   901   C0376343:Genomic Hybridization [Natural Phenomenon or Process]
   827   C0017428:Genomic [Gene or Genome]
   827   C0020202:Hybridisation [Genetic Function]
   827   C0887950:genomic [Biomedical Occupation or Discipline]
   827   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.207: Blood 1998; 

Phrase: "Blood 1998"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.208: 91: 30073010.[Abstract/Free FullText] 4. 

Phrase: "91"

Phrase: ":"

Phrase: "30073010."

Phrase: "[Abstract/Free FullText"

Phrase: "] 4."
Processing 00000000.tx.209: Sawyer JR, Lukacs JL, Thomas EL et al. 

Phrase: "Sawyer JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Lukacs JL,"

Phrase: "Thomas EL et al."
Processing 00000000.tx.210: Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma. 

Phrase: "Multicolour spectral karyotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1135935:Spectral Karyotyping [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0022526:Karyotyping [Laboratory Procedure]

Phrase: "identifies"

Phrase: "new translocations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040715:Translocations [Cell or Molecular Dysfunction]
   827 E C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "a recurring pathway for chromosome loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "in multiple myeloma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.211: Br J Haematol 2001; 

Phrase: "Br J Haematol 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.212: 112: 167174.[CrossRef][ISI][Medline] 5. 

Phrase: "112"

Phrase: ":"

Phrase: "167174."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.213: Nilsson T, Hglund M, Lenhoff S et al. 

Phrase: "Nilsson T,"

Phrase: "Hglund M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lenhoff S et al."
Processing 00000000.tx.214: A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences. 

Phrase: "A pooled analysis of karyotypic patterns,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "breakpoints"

Phrase: "and"

Phrase: "imbalances in 783 cytogenetically abnormal multiple myelomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1397014:Imbalance [Sign or Symptom]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "frequently involved chromosome segments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   779   C0441635:Segment [Spatial Concept]
   729 E C0205122:Segmental [Spatial Concept]

Phrase: "as well as"

Phrase: "significant age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-related differences."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0036866:Sex Differences [Organism Attribute]
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.215: Br J Haematol 2003; 

Phrase: "Br J Haematol 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.216: 120: 960969.[CrossRef][ISI][Medline] 6. 

Phrase: "120"

Phrase: ":"

Phrase: "960969."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 6."
Processing 00000000.tx.217: Debes-Marun CS, Dewald GW, Bryant S et al. 

Phrase: "Debes-Marun CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540510:cs [Quantitative Concept]

Phrase: "Dewald GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Bryant S et al."
Processing 00000000.tx.218: Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. 

Phrase: "Chromosome abnormalities"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0008625:Chromosome Abnormalities [Cell or Molecular Dysfunction]
  1000   C0008626:Chromosome Abnormalities [Disease or Syndrome]
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   861   C0008633:Chromosome [Cell Component]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "clustering"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009085:Clustering [Research Activity]
   966 E C1555715:Cluster [Idea or Concept]
   966 E C1704332:Cluster [Quantitative Concept]

Phrase: "and"

Phrase: "its implications for pathogenesis"

Phrase: "and"

Phrase: "prognosis in myeloma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033325:Prognosis [Health Care Activity]
Processing 00000000.tx.219: Leukemia 2003; 

Phrase: "Leukemia 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: ";"
Processing 00000000.tx.220: 17: 427436.[CrossRef][ISI][Medline] 7. 

Phrase: "17"

Phrase: ":"

Phrase: "427436."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 7."
Processing 00000000.tx.221: Calasanz MJ, Cigudosa JC, Odero MD et al. 

Phrase: "Calasanz MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Cigudosa JC,"

Phrase: "Odero MD et al."
Processing 00000000.tx.222: Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. 

Phrase: "Cytogenetic analysis of 280 patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0752095:Cytogenetic Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "with multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "and"

Phrase: "related disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: ":"

Phrase: "primary breakpoints"

Phrase: "and"

Phrase: "clinical correlations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.223: Genes Chromosom Cancer 1997; 

Phrase: "Genes Chromosom Cancer 1997"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0919437:genes cancer [Gene or Genome]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0017337:Genes [Gene or Genome]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ";"
Processing 00000000.tx.224: 18: 8493.[CrossRef][ISI][Medline] 8. 

Phrase: "18"

Phrase: ":"

Phrase: "8493."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8."
Processing 00000000.tx.225: Avet-Loiseau H, Facon T, Grosbois B et al. 

Phrase: "Avet-Loiseau H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Facon T,"

Phrase: "Grosbois B et al."
Processing 00000000.tx.226: Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. 

Phrase: "Oncogenesis of multiple myeloma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007621:Oncogenesis [Neoplastic Process]
   770   C0596263:Oncogenesis [Neoplastic Process]

Phrase: ":"

Phrase: "14q32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520599:14q32 [Cell Component]

Phrase: "and"

Phrase: "13q chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   901   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "are"

Phrase: "not randomly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "correlate with natural history,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0175860:Natural History [Occupation or Discipline]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0205296:Natural [Functional Concept]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "immunological features,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "clinical presentation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2708283:Clinical presentation [Intellectual Product]
   861   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.227: Blood 2002; 

Phrase: "Blood 2002"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.228: 99: 21852191.[Abstract/Free FullText] 9. 

Phrase: "99"

Phrase: ":"

Phrase: "21852191."

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.229: Garand R, Avet-Loiseau H, Accard F et al. 

Phrase: "Garand R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Avet-Loiseau H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Accard F et al."
Processing 00000000.tx.230: t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma. 

Phrase: "t(11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ")"

Phrase: "and"

Phrase: "t(4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3641140:T-4 [Spatial Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ")"

Phrase: "translocations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040715:Translocations [Cell or Molecular Dysfunction]
   966 E C2987521:Translocation [Activity]

Phrase: "correlated with mature lymphoplasmacytoid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205286:Mature [Temporal Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "and"

Phrase: "immature morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "respectively,"

Phrase: "in multiple myeloma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.231: Leukemia 2003; 

Phrase: "Leukemia 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: ";"
Processing 00000000.tx.232: 17: 20322035.[CrossRef][ISI][Medline] 10. 

Phrase: "17"

Phrase: ":"

Phrase: "20322035."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 10."
Processing 00000000.tx.233: Smadja NV, Fruchart C, Isnard F et al. 

Phrase: "Smadja NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "Fruchart C,"

Phrase: "Isnard F et al."
Processing 00000000.tx.234: Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases. 

Phrase: "Chromosomal analysis in multiple myeloma"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0853259:chromosomal analysis [Laboratory Procedure]
   770 E C0200867:Chromosome analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "cytogenetic evidence of two different diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.235: Leukemia 1998; 

Phrase: "Leukemia 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023418:Leukaemia [Neoplastic Process]

Phrase: ";"
Processing 00000000.tx.236: 12: 960969.[CrossRef][ISI][Medline] 11. 

Phrase: "12"

Phrase: ":"

Phrase: "960969."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11."
Processing 00000000.tx.237: Fonseca R, Barlogie B, Bataille R et al. 

Phrase: "Fonseca R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Barlogie B,"

Phrase: "Bataille R et al."
Processing 00000000.tx.238: Genetics and cytogenetics of multiple myeloma: A workshop report. 

Phrase: "Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "cytogenetics of multiple myeloma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "A workshop report."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]
Processing 00000000.tx.239: Cancer Res 2004; 

Phrase: "Cancer Res 2004"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ";"
Processing 00000000.tx.240: 64: 15461558.[Abstract/Free FullText] 12. 

Phrase: "64"

Phrase: ":"

Phrase: "15461558."

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.241: Smadja NV, Bastard C, Brigaudeau C et al. 

Phrase: "Smadja NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "Bastard C,"

Phrase: "Brigaudeau C et al."
Processing 00000000.tx.242: Hypodiploidy is a major prognostic factor in multiple myeloma. 

Phrase: "Hypodiploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333691:Hypodiploidy [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a major prognostic factor in multiple myeloma."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1514474:Prognostic Factor [Clinical Attribute]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C0220901:prognostic [Intellectual Product]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.243: Blood 2001; 

Phrase: "Blood 2001"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.244: 98: 22292238.[Abstract/Free FullText] 13. 

Phrase: "98"

Phrase: ":"

Phrase: "22292238."

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.245: Barlogie B, Shaughnessy J, Tricot G et al. 

Phrase: "Barlogie B,"

Phrase: "Shaughnessy J,"

Phrase: "Tricot G et al."
Processing 00000000.tx.246: Treatment of multiple myeloma. 

Phrase: "Treatment of multiple myeloma."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.247: Blood 2004; 

Phrase: "Blood 2004"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.248: 103: 2032.[Abstract/Free FullText] 14. 

Phrase: "103"

Phrase: ":"

Phrase: "2032."

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.249: Calasanz MJ, Cigudosa JC, Odero MD et al. 

Phrase: "Calasanz MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Cigudosa JC,"

Phrase: "Odero MD et al."
Processing 00000000.tx.250: Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma. 

Phrase: "Hypodiploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333691:Hypodiploidy [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "22q11 rearrangements at diagnosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511695:Rearrangements [Genetic Function]

Phrase: "are"

Phrase: "associated with poor prognosis"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0278252:Poor prognosis [Finding]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0032854:Poor [Group Attribute]
   770   C0033325:Prognosis [Health Care Activity]
   770   C0542537:Poor [Qualitative Concept]
   770   C2700379:Poor [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with multiple myeloma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.251: Br J Haematol 1997; 

Phrase: "Br J Haematol 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.252: 98: 418425.[CrossRef][ISI][Medline] 15. 

Phrase: "98"

Phrase: ":"

Phrase: "418425."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 15."
Processing 00000000.tx.253: Fonseca R, Harrington D, Oken MM et al. 

Phrase: "Fonseca R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Harrington D,"

Phrase: "Oken MM et al."
Processing 00000000.tx.254: Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (13) in multiple myeloma: An Eastern Cooperative Oncology Group study. 

Phrase: "Biological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005532:Biological [Biomedical Occupation or Discipline]
  1000   C0205460:biological [Qualitative Concept]

Phrase: "and"

Phrase: "prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0237881:Significance [Quantitative Concept]
   735   C0750502:Significance [Idea or Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "in multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ":"

Phrase: "An Eastern Cooperative Oncology Group study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0596382:cooperative study [Research Activity]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]
   771   C1512162:Eastern Cooperative Oncology Group [Health Care Related Organization]
Processing 00000000.tx.255: Cancer Res 2002; 

Phrase: "Cancer Res 2002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ";"
Processing 00000000.tx.256: 62: 715720.[Abstract/Free FullText] 16. 

Phrase: "62"

Phrase: ":"

Phrase: "715720."

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.257: Knigsberg R, Zojer N, Ackermann J et al. 

Phrase: "Knigsberg R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Zojer N,"

Phrase: "Ackermann J et al."
Processing 00000000.tx.258: Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. 

Phrase: "Predictive role of interphase cytogenetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "for survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with multiple myeloma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.259: J Clin Oncol 2000; 

Phrase: "J Clin Oncol 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.260: 18: 804812.[Abstract/Free FullText] 17. 

Phrase: "18"

Phrase: ":"

Phrase: "804812."

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.261: Desikan R, Barlogie B, Sawyer J et al. 

Phrase: "Desikan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Barlogie B,"

Phrase: "Sawyer J et al."
Processing 00000000.tx.262: Results of high-dose therapy for 1000 patients with multiple myeloma: Durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. 

Phrase: "Results of high-dose therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "for 1000 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ":"

Phrase: "Durable complete remissions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   867   C0677874:Complete Remission [Finding]
   827   C0205197:Complete [Qualitative Concept]
   827   C0544452:remissions [Finding]
   827   C0687702:remissions [Neoplastic Process]
   827   C0725685:COMPLEAT [Food]
   755 E C0439812:Completeness [Qualitative Concept]

Phrase: "and"

Phrase: "superior survival in the absence of chromosome 13 abnormalities."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
Processing 00000000.tx.263: Blood 2000; 

Phrase: "Blood 2000"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.264: 95: 40084010.[Abstract/Free FullText] 18. 

Phrase: "95"

Phrase: ":"

Phrase: "40084010."

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.265: Fancon T, Avet-Loiseau H, Guillerm G et al. 

Phrase: "Fancon T,"

Phrase: "Avet-Loiseau H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Guillerm G et al."
Processing 00000000.tx.266: Chromosome 13 abnormalities identified by FISH analysis and serum 2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. 

Phrase: "Chromosome 13 abnormalities"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   913   C0008625:Chromosome Abnormalities [Cell or Molecular Dysfunction]
   913   C0008626:Chromosome Abnormalities [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]
   734   C0008655:Chromosome 13 [Cell Component]

Phrase: "identified by FISH analysis"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
           fluorescence hybridization situ
   814   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   778   C0444498:In situ [Spatial Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0020202:Hybridisation [Genetic Function]
   748   C0205396:Identified [Qualitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1300517:Hybridization [Laboratory Procedure]
   748   C1524024:analysis [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "serum 2-microglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1979927:Microglobulin [Amino Acid, Peptide, or Protein]

Phrase: "produce"

Phrase: "a powerful myeloma staging system for patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0449394:Staging system [Intellectual Product]
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "high-dose therapy."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0444956:High dose [Quantitative Concept]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0178602:Dose [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C0869039:Dose [Quantitative Concept]
   827   C1114758:Dose # [Clinical Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1363945:Therapy [Finding]
   827   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.267: Blood 2001; 

Phrase: "Blood 2001"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.268: 97: 15661571.[Abstract/Free FullText] 19. 

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "15661571."

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.269: Fassas AB, Spencer T, Sawyer J et al. 

Phrase: "Fassas AB,"

Phrase: "Spencer T,"

Phrase: "Sawyer J et al."
Processing 00000000.tx.270: Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma. 

Phrase: "Both hypodiploidy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333691:Hypodiploidy [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "deletion of chromosome 13 independently"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "confer"

Phrase: "poor prognosis in multiple myeloma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0278252:Poor prognosis [Finding]
   760   C0033325:Prognosis [Health Care Activity]
Processing 00000000.tx.271: Br J Haematol 2002; 

Phrase: "Br J Haematol 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.272: 118: 10411047.[CrossRef][ISI][Medline] 20. 

Phrase: "118"

Phrase: ":"

Phrase: "10411047."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 20."
Processing 00000000.tx.273: Shaughnessy J, Jacobson J, Sawyer J et al. 

Phrase: "Shaughnessy J,"

Phrase: "Jacobson J,"

Phrase: "Sawyer J et al."
Processing 00000000.tx.274: Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression. 

Phrase: "Continuous absence of metaphase-defined cytogenetic abnormalities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "especially of chromosome 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008655:Chromosome 13 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "and"

Phrase: "hypodiploidy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333691:Hypodiploidy [Cell or Molecular Dysfunction]

Phrase: "ensures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "long-term survival in multiple myeloma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]

Phrase: "treated with Total Therapy I"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021966:I- [Inorganic Chemical]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1363945:Therapy [Finding]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: ":"

Phrase: "interpretation in the context of global gene expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0459471:Interpretation [Intellectual Product]
   744   C3173575:Interpretation [Clinical Attribute]
Processing 00000000.tx.275: Blood 2003; 

Phrase: "Blood 2003"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.276: 101: 38493856.[Abstract/Free FullText] 21. 

Phrase: "101"

Phrase: ":"

Phrase: "38493856."

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.277: Shaughnessy J Jr, Tian E, Sawyer J et al. 

Phrase: "Shaughnessy J Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Tian E,"

Phrase: "Sawyer J et al."
Processing 00000000.tx.278: Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. 

Phrase: "Prognostic impact of cytogenetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "and"

Phrase: "interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0008628:Chromosome Deletion [Cell or Molecular Dysfunction]
   736   C1442161:Deletion [Cell or Molecular Dysfunction]
   736   C1511760:Deletion [Genetic Function]
   736   C1880274:Deletion [Activity]

Phrase: ":"

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "results of total therapy II."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1363945:Therapy [Finding]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
Processing 00000000.tx.279: Br J Haematol 2003; 

Phrase: "Br J Haematol 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.280: 120: 4452.[CrossRef][ISI][Medline] 22. 

Phrase: "120"

Phrase: ":"

Phrase: "4452."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 22."
Processing 00000000.tx.281: Tricot G, Barlogie B, Jagannath S et al. 

Phrase: "Tricot G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Barlogie B,"

Phrase: "Jagannath S et al."
Processing 00000000.tx.282: Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. 

Phrase: "Poor prognosis in multiple myeloma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0278252:Poor prognosis [Finding]
   760   C0033325:Prognosis [Health Care Activity]

Phrase: "is"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "only with partial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205171:Only [Quantitative Concept]
   790   C0728938:Partial [Quantitative Concept]
   790   C1550516:partial [Idea or Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "or"

Phrase: "complete deletions of chromosome 13"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   851   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "or"

Phrase: "abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0000768:Abnormalities [Congenital Abnormality]
  1000   C0000769:abnormalities [Functional Concept]
   966 E C1704258:Abnormality [Finding]
   916 E C0205161:Abnormal [Qualitative Concept]
   916 E C2347472:% Abnormal [Quantitative Concept]
   916 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "11q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0796366:11q [Nucleotide Sequence]

Phrase: "and"

Phrase: "not with other karyotype abnormalities."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   760   C0022526:Karyotype [Laboratory Procedure]
   760   C0178725:Karyotype [Laboratory or Test Result]
   760   C1261273:Karyotype [Organism Attribute]
   760   C1518422:Not [Functional Concept]
   756   C0476431:Abnormal Karyotype [Finding]
   756   C1547211:Not abnormal [Intellectual Product]
   726 E C1704258:Abnormality [Finding]
Processing 00000000.tx.283: Blood 1995; 

Phrase: "Blood 1995"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.284: 86: 42504256.[Abstract/Free FullText] 23. 

Phrase: "86"

Phrase: ":"

Phrase: "42504256."

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.285: Drach J, Ackermann J, Fritz E et al. 

Phrase: "Drach J,"

Phrase: "Ackermann J,"

Phrase: "Fritz E et al."
Processing 00000000.tx.286: Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. 

Phrase: "Presence of a p53 gene deletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "predicts for short survival"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C1282927:short [Qualitative Concept]
   770   C1806781:Short [Quantitative Concept]
   770   C2350002:Short [Quantitative Concept]

Phrase: "after conventional-dose chemotherapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   827   C0013217:chemotherapy [Functional Concept]
   827   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.287: Blood 1998; 

Phrase: "Blood 1998"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.288: 92: 802809.[Abstract/Free FullText] 24. 

Phrase: "92"

Phrase: ":"

Phrase: "802809."

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.289: Chang H, Sloan S, Li D et al. 

Phrase: "Chang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sloan S,"

Phrase: "Li D et al."
Processing 00000000.tx.290: The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant. 

Phrase: "The t(4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3641140:T-4 [Spatial Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ")"

Phrase: "is"

Phrase: "associated with poor prognosis"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0278252:Poor prognosis [Finding]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0032854:Poor [Group Attribute]
   770   C0033325:Prognosis [Health Care Activity]
   770   C0542537:Poor [Qualitative Concept]
   770   C2700379:Poor [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in myeloma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "undergoing"

Phrase: "autologous stem cell transplant."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C1504389:Stem cell transplant [Therapeutic or Preventive Procedure]
   902   C0559189:Transplant, Autologous [Biomedical or Dental Material]
   861   C0038250:Stem cell [Cell]
   861   C0206152:Transplant, Cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0040732:Transplant [Therapeutic or Preventive Procedure]
   812   C0242767:Stem [Plant]
   812   C0332835:Transplant [Tissue]
   812   C0439859:Autologous [Qualitative Concept]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.291: Br J Haematol 2004; 

Phrase: "Br J Haematol 2004"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.292: 125: 6468.[CrossRef][Medline] 25. 

Phrase: "125"

Phrase: ":"

Phrase: "6468."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 25."
Processing 00000000.tx.293: Johansson B, Mertens F, Mitelman F. 

Phrase: "Johansson B,"

Phrase: "Mertens F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mitelman F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.294: Geographic heterogeneity of neoplasia-associated chromosome aberrations. 

Phrase: "Geographic heterogeneity of neoplasia-associated chromosome aberrations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019409:Heterogeneity [Qualitative Concept]
Processing 00000000.tx.295: Genes Chromsome Cancer 1991; 

Phrase: "Genes Chromsome Cancer 1991"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0919437:genes cancer [Gene or Genome]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0017337:Genes [Gene or Genome]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ";"
Processing 00000000.tx.296: 3: 17. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "17."
Processing 00000000.tx.297: 26. 

Phrase: "26."
Processing 00000000.tx.298: Tien HF, Wang CH, Lin MT et al. 

Phrase: "Tien HF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]

Phrase: "Wang CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Lin MT et al."
Processing 00000000.tx.299: Correlation of cytogenetic results with immunophenotype, genotype, clinical features and ras mutation in acute myeloid leukemia: a study of 235 Chinese patients in Taiwan. 

Phrase: "Correlation of cytogenetic results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "with immunophenotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079611:Immunophenotype [Laboratory Procedure]

Phrase: "genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "ras mutation in acute myeloid leukemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "a study of 235 Chinese patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "in Taiwan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]
Processing 00000000.tx.300: Cancer Genet Cytogenet 1995; 

Phrase: "Cancer Genet Cytogenet 1995"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0325074:Genet [Mammal]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ";"
Processing 00000000.tx.301: 84: 6068.[CrossRef][ISI][Medline] 27. 

Phrase: "84"

Phrase: ":"

Phrase: "6068."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 27."
Processing 00000000.tx.302: Mitelmen F. 

Phrase: "Mitelmen F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.303: Geographic heterogeneity of chromosome aberrations in hematologic disorders. 

Phrase: "Geographic heterogeneity of chromosome aberrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "in hematologic disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018939:HEMATOLOGIC DISORDERS [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.304: Cancer Genet Cytogenet 1986; 

Phrase: "Cancer Genet Cytogenet 1986"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0325074:Genet [Mammal]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ";"
Processing 00000000.tx.305: 20: 203208.[CrossRef][ISI][Medline] 28. 

Phrase: "20"

Phrase: ":"

Phrase: "203208."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 28."
Processing 00000000.tx.306: Chen CY, Yao M, Tang JL et al. 

Phrase: "Chen CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Yao M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tang JL et al."
Processing 00000000.tx.307: Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma. 

Phrase: "Chromosomal abnormalities of 200 Chinese patients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   790   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "with non-Hodgkin's lymphoma"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024305:Lymphoma, Non-Hodgkin [Neoplastic Process]
  1000   C2700512:LYMPHOMA, NON-HODGKIN [Gene or Genome]
  1000   C3539720:Non-Hodgkin Lymphoma [Intellectual Product]
   901   C0019829:Hodgkin Lymphoma [Neoplastic Process]
   901   C3541281:Hodgkin Lymphoma [Intellectual Product]
   827   C0024299:Lymphoma [Neoplastic Process]
   827   C1518422:Non [Functional Concept]

Phrase: "in Taiwan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: ":"

Phrase: "with special reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: "to T-cell lymphoma."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0079772:T-Cell Lymphoma [Neoplastic Process]
   901   C0039194:T-cell [Cell]
   901   C0883208:cell lymphoma [Cell]
   827   C0007634:Cell [Cell]
   827   C0024299:Lymphoma [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.308: Ann Oncol 2004; 

Phrase: "Ann Oncol 2004"

Phrase: ";"
Processing 00000000.tx.309: 15: 10911096.[Abstract/Free FullText] 29. 

Phrase: "15"

Phrase: ":"

Phrase: "10911096."

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.310: Riedel DA, Pottern LM. 

Phrase: "Riedel DA,"

Phrase: "Pottern LM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]
Processing 00000000.tx.311: The epidemiology of multiple myeloma. 

Phrase: "The epidemiology of multiple myeloma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   760   C0014508:epidemiology [Functional Concept]
   760   C0699910:epidemiology [Health Care Activity]
Processing 00000000.tx.312: Hematol Oncol Clin North Am 1992; 

Phrase: "Hematol Oncol Clin North"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709269:North [Spatial Concept]

Phrase: "Am"

Phrase: "1992"

Phrase: ";"
Processing 00000000.tx.313: 6: 225247.[ISI][Medline] 30. 

Phrase: "6"

Phrase: ":"

Phrase: "225247."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 30."
Processing 00000000.tx.314: Mitelman F (ed.). 

Phrase: "Mitelman F (ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538926:ED [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.315: ISCN. 

Phrase: "ISCN."
Processing 00000000.tx.316: An International System for Human Cytogenetic Nomenclature. 

Phrase: "An International System for Human Cytogenetic Nomenclature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0449913:System [Functional Concept]
   748   C1512888:International [Idea or Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
Processing 00000000.tx.317: Basel, Switzerland: S Karger 1995. 

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ":"

Phrase: "S Karger 1995."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.318: 31. 

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.319: Ko BS, Tang JL, Lee FY et al. 

Phrase: "Ko BS,"

Phrase: "Tang JL,"

Phrase: "Lee FY et al."
Processing 00000000.tx.320: Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. 

Phrase: "Additional chromosomal abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   901   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "and"

Phrase: "variability of BCR breakpoints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827666:Variability [Conceptual Entity]

Phrase: "in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   923   C1960397:Philadelphia chromosome-positive acute lymphoblastic leukaemia [Neoplastic Process]
   918   C0023453:Leukemia, Lymphoblastic, Acute, Philadelphia-Positive [Neoplastic Process]
   918   C1709527:Philadelphia Positive Acute Lymphoblastic Leukemia [Neoplastic Process]
   835   C0023449:Acute lymphoblastic leukaemia [Neoplastic Process]
           Lymphoblastic leukaemia
   835   C1961102:Lymphoblastic Leukemia, Acute [Neoplastic Process]
           Lymphoblastic Leukemia
   835   C3542401:Acute Lymphoblastic Leukemia [Intellectual Product]
   822   C0085669:Acute leukaemia [Neoplastic Process]
   822   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   812   C0023448:Lymphoblastic leukemia [Neoplastic Process]
   793   C0023418:Leukaemia [Neoplastic Process]
   793   C0205178:acute [Temporal Concept]
   793   C0229613:lymphoblastic [Cell]
   721 E C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "in Taiwan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]
Processing 00000000.tx.321: Am J Hematol 2002; 

Phrase: "Am"

Phrase: "J Hematol 2002"

Phrase: ";"
Processing 00000000.tx.322: 71: 291299.[CrossRef][ISI][Medline] 32. 

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "291299."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 32."
Processing 00000000.tx.323: Ahmann GJ, Jalal SM, Juneau AL et al. 

Phrase: "Ahmann GJ,"

Phrase: "Jalal SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Juneau AL et al."
Processing 00000000.tx.324: A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies. 

Phrase: "A novel three-color, clone-specific fluorescence in situ hybridization procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   790   C1948041:Procedure [Therapeutic or Preventive Procedure]
   790   C2700391:Procedure [Activity]
   790   C3274430:PROCEDURE [Health Care Activity]
   790   C3538935:Procedure [Idea or Concept]
   790   C3539779:Procedure [Intellectual Product]

Phrase: "for monoclonal gammopathies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1136085:Monoclonal Gammopathies [Neoplastic Process]
   966 E C0026470:monoclonal gammopathy [Neoplastic Process]
   861   C0178650:gammopathies [Disease or Syndrome]
   861   C0746619:monoclonal [Finding]
Processing 00000000.tx.325: Cancer Genet Cytogenet 1998; 

Phrase: "Cancer Genet Cytogenet 1998"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0325074:Genet [Mammal]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ";"
Processing 00000000.tx.326: 101: 711.[CrossRef][ISI][Medline] 33. 

Phrase: "101"

Phrase: ":"

Phrase: "711."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 33."
Processing 00000000.tx.327: Blad J, Samson D, Reece D et al. 

Phrase: "Blad J,"

Phrase: "Samson D,"

Phrase: "Reece D et al."
Processing 00000000.tx.328: Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. 

Phrase: "Criteria for evaluating disease response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "progression in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "with multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "treated by high-dose therapy"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0444956:High dose [Quantitative Concept]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0178602:Dose [Quantitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1299351:High [Qualitative Concept]
   760   C1363945:Therapy [Finding]
   760   C1522326:Treated [Functional Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "haemopoietic stem cell transplantation."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   972   C0472699:Hematopoietic Stem Cell Transplantation [Therapeutic or Preventive Procedure]
           Hematopoietic Cell Transplantation
   923   C0018956:Hemopoietic stem cell [Cell]
   923   C1504389:Stem Cell Transplantation [Therapeutic or Preventive Procedure]
   875   C2323499:Hemopoietic cell [Cell]
   861   C0038250:Stem cell [Cell]
   861   C0206153:Cell Transplantation [Therapeutic or Preventive Procedure]
   812   C0007634:Cell [Cell]
   812   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   812   C0040733:transplantation [Functional Concept]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.329: Br J Haematol 1998; 

Phrase: "Br J Haematol 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.330: 102: 11151123.[CrossRef][ISI][Medline] 34. 

Phrase: "102"

Phrase: ":"

Phrase: "11151123."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 34."
Processing 00000000.tx.331: Huang SY, Tang JL, Yao M et al. 

Phrase: "Huang SY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039138:SY [Geographic Area]
   861   C1706466:SY [Intellectual Product]

Phrase: "Tang JL,"

Phrase: "Yao M et al."
Processing 00000000.tx.332: Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma. 

Phrase: "Reduction of leukocyte count"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with thalidomide response"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0039736:Thalidomide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in treatment of multiple myeloma."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.333: Ann Hematol 2003; 

Phrase: "Ann Hematol 2003"

Phrase: ";"
Processing 00000000.tx.334: 82: 558564.[CrossRef][ISI][Medline] 35. 

Phrase: "82"

Phrase: ":"

Phrase: "558564."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 35."
Processing 00000000.tx.335: Rajkumar SV, Fonseca R, Dewald GW et al. 

Phrase: "Rajkumar SV,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013754:SV [Geographic Area]
   861   C0560132:Sv [Quantitative Concept]
   861   C1704677:SV [Idea or Concept]

Phrase: "Fonseca R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dewald GW et al."
Processing 00000000.tx.336: Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma. 

Phrase: "Cytogenetic abnormalities"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0008625:Cytogenetic Abnormalities [Cell or Molecular Dysfunction]
  1000   C0008626:Cytogenetic Abnormalities [Disease or Syndrome]
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "correlate with the plasma cell labeling index"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   853   C2698830:Plasma Cell Labeling Index [Laboratory Procedure]
           Labeling Index
   778   C0032112:Plasma cell [Cell]
   778   C0812425:Labeling Index [Laboratory or Test Result]
   748   C0007634:Cell [Cell]
   748   C0032105:Plasma [Body Substance]
   748   C0918012:Index [Intellectual Product]
   748   C1167624:Labeling [Mental Process]
   748   C1269647:Cell [Cell]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1552854:index [Idea or Concept]
   748   C1637833:% index [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1947902:Labeling [Manufactured Object]
   748   C1948049:Cell [Spatial Concept]
   748   C2827499:Labeling [Governmental or Regulatory Activity]
   714 E C0181496:Label [Manufactured Object]

Phrase: "and"

Phrase: "extent of bone marrow involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "in myeloma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026764:Myeloma [Neoplastic Process]
  1000   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.337: Cancer Genet Cytogenet 1999; 

Phrase: "Cancer Genet Cytogenet 1999"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0325074:Genet [Mammal]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ";"
Processing 00000000.tx.338: 113: 7377.[CrossRef][ISI][Medline] 36. 

Phrase: "113"

Phrase: ":"

Phrase: "7377."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 36."
Processing 00000000.tx.339: Kaufmann H, Krmer E, Nsslinger T et al. 

Phrase: "Kaufmann H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Krmer E,"

Phrase: "Nsslinger T et al."
Processing 00000000.tx.340: Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma. 

Phrase: "Both chromosome 13 abnormalities by metaphase cytogenetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0008625:Chromosome Abnormalities [Cell or Molecular Dysfunction]
   774   C0008626:Chromosome Abnormalities [Disease or Syndrome]
   748   C0000768:Abnormalities [Congenital Abnormality]
   748   C0000769:abnormalities [Functional Concept]
   714 E C1704258:Abnormality [Finding]

Phrase: "and"

Phrase: "deletion of 13q"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C2930913:Deletion 13q [Cell or Molecular Dysfunction]
   790   C1442161:Deletion [Cell or Molecular Dysfunction]
   790   C1511760:Deletion [Genetic Function]
   790   C1880274:Deletion [Activity]

Phrase: "by interphase FISH only"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   861   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   827   C0444498:In situ [Spatial Concept]
   799   C0016315:Fluorescence [Natural Phenomenon or Process]
   799   C0020202:Hybridisation [Genetic Function]
   799   C1300517:Hybridization [Laboratory Procedure]
   727 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "are"

Phrase: "prognostically relevant in multiple myeloma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.341: Eur J Haematol 2003; 

Phrase: "Eur J Haematol 2003"

Phrase: ";"
Processing 00000000.tx.342: 71: 179183.[CrossRef][ISI][Medline] 37. 

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "179183."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 37."
Processing 00000000.tx.343: Huang SY, Tien HF, Su FS, Hsu SM. 

Phrase: "Huang SY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039138:SY [Geographic Area]
   861   C1706466:SY [Intellectual Product]

Phrase: "Tien HF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]

Phrase: "Su FS,"

Phrase: "Hsu SM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]
Processing 00000000.tx.344: Non-irradiated NOD/SCID-human chimeric animal model for primary human multiple myelomaa potential in vivo culture system. 

Phrase: "Non-irradiated NOD/SCID-human chimeric animal model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0599779:Animal Model [Animal]
   793   C0003062:Animal [Animal]
   793   C3161035:Model [Intellectual Product]

Phrase: "for primary human multiple myelomaa potential in vivo culture system."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   791   C0010453:Culture [Idea or Concept]
   791   C0220814:culture [Functional Concept]
   791   C0430400:Culture [Laboratory Procedure]
   791   C0449913:System [Functional Concept]
   791   C1553451:System [Manufactured Object]
   791   C1704459:System [Medical Device]
   791   C2242979:Culture [Laboratory Procedure]
   720 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.345: Am J Pathol 2004; 

Phrase: "Am"

Phrase: "J Pathol 2004"

Phrase: ";"
Processing 00000000.tx.346: 164: 747756.[Abstract/Free FullText] 38. 

Phrase: "164"

Phrase: ":"

Phrase: "747756."

Phrase: "[Abstract/Free FullText"

Phrase: "] 38."
Processing 00000000.tx.347: Taniwaki M, Nishida K, Takashima T et al. 

Phrase: "Taniwaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nishida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Takashima T et al."
Processing 00000000.tx.348: Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. 

Phrase: "Nonrandom chromosomal rearrangements of 14q32.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1515001:Chromosomal Rearrangement [Cell or Molecular Dysfunction]
   753   C1511695:Rearrangements [Genetic Function]

Phrase: "and"

Phrase: "19p13.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1520850:19p13.3 [Cell Component]
   861   C1520840:19p13 [Cell Component]

Phrase: "and"

Phrase: "preferential deletion of 1p"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0795796:Deletion 1p [Disease or Syndrome]
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "in 21 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "and"

Phrase: "plasma cell leukemia."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0023484:Leukemia, Plasma Cell [Neoplastic Process]
   901   C0032112:Plasma cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0032105:Plasma [Body Substance]
   827   C1269647:Cell [Cell]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.349: Blood 1994; 

Phrase: "Blood 1994"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.350: 84: 22832290.[Abstract/Free FullText] 39. 

Phrase: "84"

Phrase: ":"

Phrase: "22832290."

Phrase: "[Abstract/Free FullText"

Phrase: "] 39."
Processing 00000000.tx.351: Mellentin JD, Murre C, Donlon TA et al. 

Phrase: "Mellentin JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Murre C,"

Phrase: "Donlon TA et al."
Processing 00000000.tx.352: The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. 

Phrase: "The gene for enhancer binding proteins E12/E47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0751455:Gene Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]

Phrase: "lies at the t(1"

Phrase: ";19"

Phrase: ")"

Phrase: "breakpoint in acute leukemias."
Processing 00000000.tx.353: Science 1989; 

Phrase: "Science 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ";"
Processing 00000000.tx.354: 246: 379382.[ISI][Medline] 40. 

Phrase: "246"

Phrase: ":"

Phrase: "379382."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.355: Kaname T, Miyauchi T, Kuwano A et al. 

Phrase: "Kaname T,"

Phrase: "Miyauchi T,"

Phrase: "Kuwano"

Phrase: "A et al."
Processing 00000000.tx.356: Mapping basigin (BSG), a member of the immunoglobulin superfamily, to 19p13.3. 

Phrase: "Mapping basigin (BSG),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0081714:Basigin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1412828:BASIGIN [Gene or Genome]

Phrase: "a member of the immunoglobulin superfamily,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "to 19p13.3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1520850:19p13.3 [Cell Component]
   861   C1520840:19p13 [Cell Component]
Processing 00000000.tx.357: Cytogenet Cell Genet 1993; 

Phrase: "Cytogenet Cell Genet 1993"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0007634:Cell [Cell]
   812   C0325074:Genet [Mammal]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.358: 64: 195197.[ISI][Medline] 41. 

Phrase: "64"

Phrase: ":"

Phrase: "195197."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 41."
Processing 00000000.tx.359: Gozzetti A, Davis EM, Espinosa R et al. 

Phrase: "Gozzetti A,"

Phrase: "Davis EM,"

Phrase: "Espinosa R et al."
Processing 00000000.tx.360: Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas. 

Phrase: "Identification of novel cryptic translocations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "IGH in B-cell non-Hodgkin's lymphomas."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017351:IGH [Gene or Genome]
   720   C0079731:B-Cell Non-Hodgkin Lymphoma [Neoplastic Process]
Processing 00000000.tx.361: Cancer Res 2002; 

Phrase: "Cancer Res 2002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C2347379:RES [Finding]

Phrase: ";"
Processing 00000000.tx.362: 62: 55235527.[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 16/9/1530 most recent mdi273v1 E-letters: Submit a response Alert me when this article is cited Alert me when E-letters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Disclaimer Request Permissions Google Scholar Articles by Huang, S.-Y. 

Phrase: "62"

Phrase: ":"

Phrase: "55235527."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "16/9/1530 most recent mdi273v1 E-letters"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   793   C0282413:letters [Intellectual Product]
   760 E C1096774:Letter [Intellectual Product]
   760 E C2360551:Letter [Clinical Attribute]
   721 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   700 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ":"

Phrase: "Submit"

Phrase: "a response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "E-letters"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "are"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Disclaimer Request Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706852:Article [Intellectual Product]

Phrase: "by Huang,"

Phrase: "S.-"

Phrase: "Y."
Processing 00000000.tx.363: Articles by Tien, H.-F. 

Phrase: "Articles by Tien,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "H.-F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.364: PubMed PubMed Citation Articles by Huang, S.-Y. 

Phrase: "PubMed PubMed Citation Articles by Huang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "S.-"

Phrase: "Y."
Processing 00000000.tx.365: Articles by Tien, H.-F. 

Phrase: "Articles by Tien,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "H.-F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.366: Online ISSN 1569-8041 - Print ISSN 0923-7534 Copyright  2006 European Society for Medical Oncology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1569-8041 - Print ISSN 0923-7534 Copyright  2006 European Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0037455:society [Organization]

Phrase: "for Medical Oncology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C2735290:Privacy policy [Intellectual Product]
   787   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

